<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.0.38">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Vascular Surgery Exam Prep - 3&nbsp; Upper Extremity</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./hemodialysis.html" rel="next">
<link href="./cerebrovascular.html" rel="prev">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script>
<script async="" src="https://www.googletagmanager.com/gtag/js?id=G-T4DWNE55D1"></script>

<script type="text/javascript">

window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'G-T4DWNE55D1', { 'anonymize_ip': true});
</script>
<script async="" src="https://hypothes.is/embed.js"></script>


</head>

<body class="nav-sidebar floating">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
    <div class="container-fluid d-flex justify-content-between">
      <h1 class="quarto-secondary-nav-title"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Upper Extremity</span></h1>
      <button type="button" class="quarto-btn-toggle btn" aria-label="Show secondary navigation">
        <i class="bi bi-chevron-right"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="./">Vascular Surgery Exam Prep</a> 
        <div class="sidebar-tools-main">
    <a href="https://github.com/adam-mdmph/vs-examprep.git" title="Source Code" class="sidebar-tool px-1"><i class="bi bi-github"></i></a>
    <a href="https://twitter.com/intent/tweet?url=|url|" title="Twitter" class="sidebar-tool px-1"><i class="bi bi-twitter"></i></a>
</div>
    </div>
      </div>
      <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
      </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link">Preface</a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./authors.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Authors and Contributors</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./cerebrovascular.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Cerebrovascular</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./upper-extremity.html" class="sidebar-item-text sidebar-link active"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Upper Extremity</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./hemodialysis.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Angioaccess</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./thoracic-aorta.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Thoracic Aorta</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./abdominal-aneurysms.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Abdominal Aneurysms</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./lower-extremity.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Lower Extremity</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./renal.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Renal</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./mesenteric.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Mesenteric Disease</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./vascular-trauma.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">Vascular Trauma</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./venous-disease.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">11</span>&nbsp; <span class="chapter-title">Venous Disease</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./vascular-lab.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">12</span>&nbsp; <span class="chapter-title">Vascular Lab</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./endovascular.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">13</span>&nbsp; <span class="chapter-title">Endovascular</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./references.html" class="sidebar-item-text sidebar-link">References</a>
  </div>
</li>
    </ul>
    </div>
</nav>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#overview-of-upper-extremity-disease" id="toc-overview-of-upper-extremity-disease" class="nav-link active" data-scroll-target="#overview-of-upper-extremity-disease"> <span class="header-section-number">3.1</span> Overview of Upper Extremity Disease</a>
  <ul class="collapse">
  <li><a href="#anatomy" id="toc-anatomy" class="nav-link" data-scroll-target="#anatomy"> <span class="header-section-number">3.1.1</span> Anatomy</a></li>
  <li><a href="#epidemiology-etiology-and-diagnostic-evaluation" id="toc-epidemiology-etiology-and-diagnostic-evaluation" class="nav-link" data-scroll-target="#epidemiology-etiology-and-diagnostic-evaluation"> <span class="header-section-number">3.1.2</span> Epidemiology, Etiology, and Diagnostic Evaluation</a></li>
  <li><a href="#evaluation" id="toc-evaluation" class="nav-link" data-scroll-target="#evaluation"> <span class="header-section-number">3.1.3</span> Evaluation</a></li>
  </ul></li>
  <li><a href="#vaso-occlusive-disease" id="toc-vaso-occlusive-disease" class="nav-link" data-scroll-target="#vaso-occlusive-disease"> <span class="header-section-number">3.2</span> Vaso-occlusive Disease</a>
  <ul class="collapse">
  <li><a href="#acute-limb-ischemia" id="toc-acute-limb-ischemia" class="nav-link" data-scroll-target="#acute-limb-ischemia"> <span class="header-section-number">3.2.1</span> Acute Limb Ischemia</a></li>
  <li><a href="#chronic-limb-threatening-ischemia" id="toc-chronic-limb-threatening-ischemia" class="nav-link" data-scroll-target="#chronic-limb-threatening-ischemia"> <span class="header-section-number">3.2.2</span> Chronic Limb Threatening Ischemia</a></li>
  </ul></li>
  <li><a href="#vasospastic-disorders" id="toc-vasospastic-disorders" class="nav-link" data-scroll-target="#vasospastic-disorders"> <span class="header-section-number">3.3</span> Vasospastic Disorders</a>
  <ul class="collapse">
  <li><a href="#iatrogenic-or-vasopressor-induced-ischemia" id="toc-iatrogenic-or-vasopressor-induced-ischemia" class="nav-link" data-scroll-target="#iatrogenic-or-vasopressor-induced-ischemia"> <span class="header-section-number">3.3.1</span> Iatrogenic or Vasopressor Induced Ischemia</a></li>
  <li><a href="#raynauds-phenomenon" id="toc-raynauds-phenomenon" class="nav-link" data-scroll-target="#raynauds-phenomenon"> <span class="header-section-number">3.3.2</span> Raynaud’s Phenomenon</a></li>
  <li><a href="#ergotism" id="toc-ergotism" class="nav-link" data-scroll-target="#ergotism"> <span class="header-section-number">3.3.3</span> Ergotism</a></li>
  <li><a href="#buergers-disease" id="toc-buergers-disease" class="nav-link" data-scroll-target="#buergers-disease"> <span class="header-section-number">3.3.4</span> Buerger’s Disease</a></li>
  <li><a href="#large-vasculitis" id="toc-large-vasculitis" class="nav-link" data-scroll-target="#large-vasculitis"> <span class="header-section-number">3.3.5</span> Large Artery Vasculitis</a></li>
  <li><a href="#other-vasculitis-syndromes" id="toc-other-vasculitis-syndromes" class="nav-link" data-scroll-target="#other-vasculitis-syndromes"> <span class="header-section-number">3.3.6</span> Other Vasculitis syndromes</a></li>
  </ul></li>
  <li><a href="#aneurysmal-disease" id="toc-aneurysmal-disease" class="nav-link" data-scroll-target="#aneurysmal-disease"> <span class="header-section-number">3.4</span> Aneurysmal Disease</a>
  <ul class="collapse">
  <li><a href="#subclavian-artery-aneurysms" id="toc-subclavian-artery-aneurysms" class="nav-link" data-scroll-target="#subclavian-artery-aneurysms"> <span class="header-section-number">3.4.1</span> Subclavian Artery Aneurysms</a></li>
  <li><a href="#axillary-artery-aneurysms" id="toc-axillary-artery-aneurysms" class="nav-link" data-scroll-target="#axillary-artery-aneurysms"> <span class="header-section-number">3.4.2</span> Axillary Artery Aneurysms</a></li>
  <li><a href="#brachial-artery-aneurysms" id="toc-brachial-artery-aneurysms" class="nav-link" data-scroll-target="#brachial-artery-aneurysms"> <span class="header-section-number">3.4.3</span> Brachial Artery Aneurysms</a></li>
  <li><a href="#radial-artery-pseudoaneurysm" id="toc-radial-artery-pseudoaneurysm" class="nav-link" data-scroll-target="#radial-artery-pseudoaneurysm"> <span class="header-section-number">3.4.4</span> Radial Artery Pseudoaneurysm</a></li>
  </ul></li>
  <li><a href="#occupational-vascular-disease" id="toc-occupational-vascular-disease" class="nav-link" data-scroll-target="#occupational-vascular-disease"> <span class="header-section-number">3.5</span> Occupational Vascular Disease</a>
  <ul class="collapse">
  <li><a href="#hand-arm-vibration-syndrome" id="toc-hand-arm-vibration-syndrome" class="nav-link" data-scroll-target="#hand-arm-vibration-syndrome"> <span class="header-section-number">3.5.1</span> Hand-Arm Vibration Syndrome</a></li>
  <li><a href="#hypothenar-hammer-syndrome" id="toc-hypothenar-hammer-syndrome" class="nav-link" data-scroll-target="#hypothenar-hammer-syndrome"> <span class="header-section-number">3.5.2</span> Hypothenar hammer syndrome</a></li>
  <li><a href="#environmental-exposures" id="toc-environmental-exposures" class="nav-link" data-scroll-target="#environmental-exposures"> <span class="header-section-number">3.5.3</span> Environmental Exposures</a></li>
  <li><a href="#sports-medicine" id="toc-sports-medicine" class="nav-link" data-scroll-target="#sports-medicine"> <span class="header-section-number">3.5.4</span> Sports Medicine</a></li>
  </ul></li>
  <li><a href="#vascular-trauma-upper-extremity" id="toc-vascular-trauma-upper-extremity" class="nav-link" data-scroll-target="#vascular-trauma-upper-extremity"> <span class="header-section-number">3.6</span> Vascular Trauma-Upper Extremity</a>
  <ul class="collapse">
  <li><a href="#subclavian-artery-trauma" id="toc-subclavian-artery-trauma" class="nav-link" data-scroll-target="#subclavian-artery-trauma"> <span class="header-section-number">3.6.1</span> Subclavian Artery Trauma</a></li>
  <li><a href="#axillary-artery-trauma" id="toc-axillary-artery-trauma" class="nav-link" data-scroll-target="#axillary-artery-trauma"> <span class="header-section-number">3.6.2</span> Axillary Artery Trauma</a></li>
  <li><a href="#brachial-artery-trauma" id="toc-brachial-artery-trauma" class="nav-link" data-scroll-target="#brachial-artery-trauma"> <span class="header-section-number">3.6.3</span> Brachial Artery Trauma</a></li>
  <li><a href="#radialulnar-artery-trauma" id="toc-radialulnar-artery-trauma" class="nav-link" data-scroll-target="#radialulnar-artery-trauma"> <span class="header-section-number">3.6.4</span> Radial/ulnar artery trauma</a></li>
  </ul></li>
  <li><a href="#compression-syndromes" id="toc-compression-syndromes" class="nav-link" data-scroll-target="#compression-syndromes"> <span class="header-section-number">3.7</span> Compression Syndromes</a>
  <ul class="collapse">
  <li><a href="#quadrilateral-space-syndrome" id="toc-quadrilateral-space-syndrome" class="nav-link" data-scroll-target="#quadrilateral-space-syndrome"> <span class="header-section-number">3.7.1</span> Quadrilateral space syndrome</a></li>
  <li><a href="#humeral-head-compression-of-axillary-artery" id="toc-humeral-head-compression-of-axillary-artery" class="nav-link" data-scroll-target="#humeral-head-compression-of-axillary-artery"> <span class="header-section-number">3.7.2</span> Humeral head compression of axillary artery</a></li>
  </ul></li>
  <li><a href="#thoracic-outlet-syndrome" id="toc-thoracic-outlet-syndrome" class="nav-link" data-scroll-target="#thoracic-outlet-syndrome"> <span class="header-section-number">3.8</span> Thoracic Outlet Syndrome</a>
  <ul class="collapse">
  <li><a href="#anatomy-1" id="toc-anatomy-1" class="nav-link" data-scroll-target="#anatomy-1"> <span class="header-section-number">3.8.1</span> Anatomy</a></li>
  <li><a href="#presentation-5" id="toc-presentation-5" class="nav-link" data-scroll-target="#presentation-5"> <span class="header-section-number">3.8.2</span> Presentation</a></li>
  <li><a href="#evaluation-9" id="toc-evaluation-9" class="nav-link" data-scroll-target="#evaluation-9"> <span class="header-section-number">3.8.3</span> Evaluation</a></li>
  <li><a href="#management-9" id="toc-management-9" class="nav-link" data-scroll-target="#management-9"> <span class="header-section-number">3.8.4</span> Management</a></li>
  <li><a href="#vtos" id="toc-vtos" class="nav-link" data-scroll-target="#vtos"> <span class="header-section-number">3.8.5</span> vTOS</a></li>
  <li><a href="#atos" id="toc-atos" class="nav-link" data-scroll-target="#atos"> <span class="header-section-number">3.8.6</span> aTOS</a></li>
  <li><a href="#ntos" id="toc-ntos" class="nav-link" data-scroll-target="#ntos"> <span class="header-section-number">3.8.7</span> nTOS</a></li>
  </ul></li>
  <li><a href="#upper-extremity-lymphedema" id="toc-upper-extremity-lymphedema" class="nav-link" data-scroll-target="#upper-extremity-lymphedema"> <span class="header-section-number">3.9</span> Upper Extremity Lymphedema</a>
  <ul class="collapse">
  <li><a href="#etiology-8" id="toc-etiology-8" class="nav-link" data-scroll-target="#etiology-8"> <span class="header-section-number">3.9.1</span> Etiology</a></li>
  <li><a href="#management-13" id="toc-management-13" class="nav-link" data-scroll-target="#management-13"> <span class="header-section-number">3.9.2</span> Management</a></li>
  </ul></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title d-none d-lg-block"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Upper Extremity</span></h1>
</div>



<div class="quarto-title-meta">

    
    
  </div>
  

</header>

<p><strong>UNDER CONSTRUCTION - This Chapter is Currently in DRAFT mode</strong></p>
<p><strong>21 Jan 2021</strong>: <em>Kush Sharma, MD and Ashraf Mansour, MD</em></p>
<section id="overview-of-upper-extremity-disease" class="level2" data-number="3.1">
<h2 data-number="3.1" class="anchored" data-anchor-id="overview-of-upper-extremity-disease"><span class="header-section-number">3.1</span> Overview of Upper Extremity Disease</h2>
<div class="cell">
<div class="cell-output-display">
<audio controls=""> <source src="https://traffic.libsyn.com/audiblebleeding/VSITE_Upper_Extremity_post_auphonic.mp3" type="audio/mpeg"> Your browser does not support the audio tag;  for browser support, please see:  https://www.w3schools.com/tags/tag_audio.asp </audio>
</div>
</div>
<section id="anatomy" class="level3" data-number="3.1.1">
<h3 data-number="3.1.1" class="anchored" data-anchor-id="anatomy"><span class="header-section-number">3.1.1</span> Anatomy</h3>
<p><strong>What are the zones of the upper extremity?</strong><span class="citation" data-cites="illig57UpperExtremity2019">(<a href="references.html#ref-illig57UpperExtremity2019" role="doc-biblioref">Karl A. Illig 2019</a>)</span></p>
<p>Division of the upper extremity into three zones:</p>
<ol type="1">
<li><p>Intrathoracic Zone: Inclusive of the aortic arch and its branches, innominate artery (dividing into right subclavian and right common carotid), left subclavian artery and left common carotid artery, as well as the innominate veins, and SVC.</p>
<ul>
<li>Arch classification helps determine difficulty of accessing the right innominate from a femoral approach. Type 1 innominate does not break the plane of the outer curve, Type 2 it is between the outer curve and inner curve and Type 3 it falls below the inner curve of the aortic arch.</li>
</ul></li>
<li><p>Thoracic Outlet: Extends from the base of neck to the axilla. Includes the subclavian, proximal vertebral, and proximal axillary arteries, as well as the corresponding veins).</p></li>
<li><p>Axilla to Fingers: The arm.</p></li>
</ol>
<p><strong>What are some common exposures for major upper extremity arteries?</strong><span class="citation" data-cites="illig57UpperExtremity2019 garygwindAnatomicExposuresVascular2013">(<a href="references.html#ref-illig57UpperExtremity2019" role="doc-biblioref">Karl A. Illig 2019</a>; <a href="references.html#ref-garygwindAnatomicExposuresVascular2013" role="doc-biblioref">Gary G Wind and R. James Valentine 2013</a>)</span></p>
<ol type="1">
<li><p><strong>Proximal Right Subclavian Artery:</strong> Access through a median sternotomy.</p></li>
<li><p><strong>Proximal Left Subclavian Artery:</strong> An anterolateral thoracotomy is required in emergent settings for proximal left subclavian artery control. For proximal, mid and distal exposure is required a “trap door” exposure is used: anterolateral thoracotomy, third space sternotomy, and left supraclavicular incision.</p></li>
<li><p><strong>Mid and Distal Subclavian Artery</strong>: Access through a supraclavicular Incision. After division of the platysma and clavicular head of the SCM, a fat pat of varying thickness is encountered which contains the omohyoid muscle. This should be divided and placed supero-laterally. At this point, the anterior scalene muscle is exposed medially with the phrenic nerve running in a lateral to medial direction, which should be identified and preserved. In a carotid/subclavian bypass division of the anterior scalene should be performed as close to the first rib as possible. Once divided the subclavian artery is exposed.</p></li>
<li><p><strong>Axillary Artery:</strong> Exposure is gained through an infraclavicular incision, below the middle third of the clavicle. Pectoralis major is divided and pectoralis minor is freed at the lateral margin of the wound. The axillary vein should be identified and followed supero-deeply to identify and expose the artery. Anatomically bound by the first rib proximally and the lateral edge of the teres major muscle distally. For exposure of the first part of the axillary artery, the ipsilateral arm is abducted approximately 90 degrees and a horizontal skin incision 2 cm below the middle third of the clavicle should be made. The underlying pectoralis major is split by bluntly separating the fibers, exposing the tough clavipectoral fascia. At the lateral wound margin, the pectoralis minor can be freed and laterally retracted. The axillary vein is the first structure to be encountered in the fascia and the artery lies just superior and deep to the vein. Make sure to protect the nerves of the brachial plexus which lie deep to the first part of axillary artery and are at risk of injury during blind placement of occluding arterial clamps.</p></li>
<li><p><strong>Brachial Artery, Upper Arm:</strong> The brachial artery’s superficial location makes it vulnerable to injury and accounts for most vascular injuries of the upper extremities. Brachial artery exposure involves a 5-8 cm longitudinal incision in the groove between the biceps/triceps muscles on the medial aspect of the arm. In the lower half of the arm, take care to avoid basilic vein damage as it runs in the subcutaneous tissue. The neurovascular bundle is exposed by incising the deep fascia at the medial border of the biceps muscle, which then should be retracted anteriorly. The basilic vein should be identified and retracted into the posterior wound. On opening the brachial sheath the median nerve is the most superficial structure and should be identified, protected and retracted. The brachial artery lies deep to the median nerve and is flanked by two brachial veins. Be mindful that the ulnar nerve lies posteriorly.</p></li>
<li><p><strong>Brachial Artery, Antecubital Fossa:</strong> Exposure of the brachial artery in the antecubital fossa requires a transverse skin incision 1 cm distal to the midpoint of the antecubital crease. After deepening, mobilize the basilic vein medially to avoid injury. The medial antebrachial cutaneous nerve should be identified and protected. The bicipital aponeurosis should be divided to exposure the brachial artery, which is flanked by two deep veins crossing tributaries. To isolate the brachial artery ligation and division of these tributaries is required. The brachial artery bifurcates at the radial tuberosity into its radial and ulnar branches. Immediately after the ulnar artery arises from the bifurcation origin, it gives off a short common interosseous branch, which bifurcates at the hiatus in the proximal interosseous membrane.</p></li>
<li><p><strong>Radial Artery at the Wrist:</strong> This requires a 2-3 cm longitudinal incision generally between the palpable radial artery and cephalic vein. Incision of the antebrachial fascia medially to the radius should expose the radial artery. Two veins accompany the artery and should be dissected away to isolate the artery. The superficial radial nerve and its medial/lateral branches course between the cephalic vein and radial artery in this area.</p></li>
<li><p><strong>Ulnar Artery:</strong> The ulnar artery courses beneath the superficial flexor muscles of the proximal forearm, emerging near the ulnar border at the midpoint between the elbow and the wrist. In the distal forearm, the ulnar artery runs just deep to the antebrachial fascia and is easily exposed through a longitudinal incision placed radially to the flexor carpi ulnaris. The palmar branch of the ulnar nerve courses superficially to the antebrachial fascia and should be preserved during arterial exposure to avoid injury.</p></li>
</ol>
<p><strong>What common aberrant upper extremity/arch anatomy is important to be aware of?</strong></p>
<p>Thoracic aortic disease is associated with aberrant anatomy, with high rates of bovine arch (25%), isolated L vertebral (6-8%), and aberrant R subclavian (1-2%).<span class="citation" data-cites="dumfarth2015">(<a href="references.html#ref-dumfarth2015" role="doc-biblioref">Dumfarth et al. 2015</a>)</span></p>
<ol type="1">
<li><p><strong>Bovine Arch:</strong> Where the innominate and left common carotid arteries share a common origin.<span class="citation" data-cites="layton2006">(<a href="references.html#ref-layton2006" role="doc-biblioref">Layton et al. 2006</a>)</span></p></li>
<li><p><strong>Aberrant Vertebral Artery:</strong> Where the vertebral artery arises directly from the aortic arch.</p></li>
<li><p><strong>Aberrant Right Subclavian Artery:</strong> Where there is no innominate artery and instead the right common carotid arises directly from the aorta. Confusingly the right subclavian artery, then originates from the aortic arch distal to the left subclavian artery. To supply the right arm it therefore, needs to pass behind the esophagus. (Dysphagia Lusoria)</p></li>
</ol>
</section>
<section id="epidemiology-etiology-and-diagnostic-evaluation" class="level3" data-number="3.1.2">
<h3 data-number="3.1.2" class="anchored" data-anchor-id="epidemiology-etiology-and-diagnostic-evaluation"><span class="header-section-number">3.1.2</span> Epidemiology, Etiology, and Diagnostic Evaluation</h3>
<p><strong>How does evaluation of upper extremity ischemia differentiate from lower extremity ischemia?</strong></p>
<ul>
<li><p>Upper extremity ischemia &lt;5% of patients with limb ischemia and in contrast to lower extremity, atherosclerosis is not a major contributor to upper extremity ischemia<span class="citation" data-cites="shuja117UpperExtremity">(<a href="references.html#ref-shuja117UpperExtremity" role="doc-biblioref">Shuja, n.d.</a>)</span></p></li>
<li><p>Vast majority of cases caused by autoimmune/connective tissue disorders</p></li>
</ul>
<p><strong>How can upper extremity disease be classified?</strong></p>
<p>Anatomic Location:</p>
<ul>
<li>Large vs.&nbsp;Small Vessel</li>
</ul>
<p>Disease Process:</p>
<ul>
<li>Vaso-occlusive disease often requires endovascular/surgical management.</li>
<li>Vasospastic disease is more responsive to pharmacological management.</li>
</ul>
</section>
<section id="evaluation" class="level3" data-number="3.1.3">
<h3 data-number="3.1.3" class="anchored" data-anchor-id="evaluation"><span class="header-section-number">3.1.3</span> Evaluation</h3>
<p><strong>How should patients be evaluated who have concern for upper extremity disease?</strong></p>
<ol type="1">
<li><p>Detailed H+P evaluation (pulse palpation, auscultation at supraclavicular/infraclavicular fossa may reveal a bruit concerning for subclavian artery stenosis, upper extremity neurovascular/skin exam)</p></li>
<li><p>Brachial/forearm blood pressures and if suspected claudication, measured at rest and 2-5 minutes after exercise. Look for a gradient of &gt;20 mmHg is considered significant</p></li>
<li><p>Some or all of 6 P’s of acute limb ischemia with symptoms occurring within 14 days are deemed acute</p></li>
<li><p>Doppler insonation of radial, ulnar, palmar, and digital arteries</p></li>
<li><p>Vascular Lab Evaluation</p>
<ol type="1">
<li><p>Segmental Pressure Measurements</p></li>
<li><p>Duplex Ultrasound (look for large vessel occlusive disease)</p></li>
</ol></li>
<li><p>Other Imaging</p>
<ol type="1">
<li>CTA/MRA</li>
</ol></li>
<li><p>Clinical Lab tests</p>
<ol type="1">
<li><p>Inflammatory disorders-CBC, ESR, ANA, RF</p></li>
<li><p>Hypercoagulable screening</p></li>
</ol></li>
</ol>
</section>
</section>
<section id="vaso-occlusive-disease" class="level2" data-number="3.2">
<h2 data-number="3.2" class="anchored" data-anchor-id="vaso-occlusive-disease"><span class="header-section-number">3.2</span> Vaso-occlusive Disease</h2>
<section id="acute-limb-ischemia" class="level3" data-number="3.2.1">
<h3 data-number="3.2.1" class="anchored" data-anchor-id="acute-limb-ischemia"><span class="header-section-number">3.2.1</span> Acute Limb Ischemia</h3>
<p><strong>What is the procedure of choice in acute limb ischemia of the upper extremity?</strong></p>
<p>With acute presentation of upper limb ischemia and a localizing examination, may be reasonable to proceed directly to OR for embolectomy to minimize ischemia time.<span class="citation" data-cites="wahlberg2006 henke2009">(<a href="references.html#ref-wahlberg2006" role="doc-biblioref">Wahlberg, Goldstone, and Olofsson 2006</a>; <a href="references.html#ref-henke2009" role="doc-biblioref">Henke 2009</a>)</span></p>
<p><strong>What are some postoperative complications of an embolectomy for acute limb ischemia?</strong></p>
<p>Brachial sheath hematoma - parasthesias and weakness in the median nerve distribution require emergent re-exploration and decompression. Even small hematomas that are not readily identifiable on clinical exam, can cause compression on the median nerve and are a surgical emergency.<span class="citation" data-cites="tran2011">(<a href="references.html#ref-tran2011" role="doc-biblioref">D. D. Tran and Andersen 2011</a>)</span></p>
<p>Compartment Syndrome - If prolonged ischemia or no hematoma found, and forearm compartments appear tense, then should proceed with fasciotomies to treat forearm compartment syndrome. Rarely performed prophylactically due to significant morbidity.<span class="citation" data-cites="gelberman1981 kistler2018 leversedge2011">(<a href="references.html#ref-gelberman1981" role="doc-biblioref">Gelberman et al. 1981</a>; <a href="references.html#ref-kistler2018" role="doc-biblioref">Kistler, Ilyas, and Thoder 2018</a>; <a href="references.html#ref-leversedge2011" role="doc-biblioref">Leversedge et al. 2011</a>)</span></p>
<ul>
<li><p>Three compartments - forearm volar (flexor, superficial, and deep), mobile wad (lateral), and dorsal (extensor, superficial, and deep). Volar compartments most susceptible to ischemia and compartment syndrome, most vulnerable muscle are flexor digitorum profundas and flexor pollicus longus.<span class="citation" data-cites="ronel2004">(<a href="references.html#ref-ronel2004" role="doc-biblioref">Ronel, Mtui, and Nolan 2004</a>)</span></p></li>
<li><p>Volar/Henry approach decompresses lateral and volar compartments with a single incision, includes carpal tunnel release.</p></li>
</ul>
</section>
<section id="chronic-limb-threatening-ischemia" class="level3" data-number="3.2.2">
<h3 data-number="3.2.2" class="anchored" data-anchor-id="chronic-limb-threatening-ischemia"><span class="header-section-number">3.2.2</span> Chronic Limb Threatening Ischemia</h3>
<section id="demographics-and-presentation---by-anatomic-level" class="level4" data-number="3.2.2.1">
<h4 data-number="3.2.2.1" class="anchored" data-anchor-id="demographics-and-presentation---by-anatomic-level"><span class="header-section-number">3.2.2.1</span> Demographics and Presentation - by anatomic level</h4>
<p><strong>What are causes and symptoms associated with subclavian/axillary occlusive disease?</strong> <span class="citation" data-cites="jacklcronenwettVascularDecisionMaking2020">(<a href="references.html#ref-jacklcronenwettVascularDecisionMaking2020" role="doc-biblioref">Jack L Cronenwett, Alik Farber, and Erica L. Mitchell 2020</a>)</span></p>
<ul>
<li><p>Etiology: Atherosclerosis is the most common cause of subclavian/axillary occlusive disease. Left SCA &gt; Right involvement. Less common causes include Takayasu disease, giant cell arteritis, or arterial TOS</p></li>
<li><p>Symptoms: Upper extremity arm/hand ischemia or neurologic symptoms due to subclavian-vertebral steal. Because significant collaterals, minimal pain on exertion even with subclavian occlusion</p></li>
<li><p>Innominate disease can present with complex steal syndrome from the vertebral artery.<span class="citation" data-cites="rodriguez2016">(<a href="references.html#ref-rodriguez2016" role="doc-biblioref">Rodriguez 2016</a>)</span></p></li>
</ul>
<p><strong>What are causes and symptoms associated with brachial/forearm occlusive disease?</strong></p>
<ul>
<li><p>Etiology: MCC of brachial artery occlusion is cardiac origin embolus. Atherosclerosis RARELY affects the brachial artery. Distal axillary/proximal brachial stenosis can be from repetitive trauma from crutch use.</p>
<ul>
<li>Radiation arteritis - may be seen with radiation after breast cancer therapy. Lesions characteristically tapered with smooth border. May occur alongside a brachial plexopathy.<span class="citation" data-cites="goldstein2010 modrall2003">(<a href="references.html#ref-goldstein2010" role="doc-biblioref">Goldstein et al. 2010</a>; <a href="references.html#ref-modrall2003" role="doc-biblioref">Modrall and Sadjadi 2003</a>)</span></li>
</ul></li>
<li><p>Forearm occlusive disease can be seen in advanced ESRD/DM where calcific atherosclerosis of radial/ulnar arteries is present. Less common causes include Buerger’as disease or Raynaud Phenomenon</p></li>
</ul>
</section>
<section id="management" class="level4" data-number="3.2.2.2">
<h4 data-number="3.2.2.2" class="anchored" data-anchor-id="management"><span class="header-section-number">3.2.2.2</span> Management</h4>
<p><strong>How/when is upper extremity occlusive disease treated?</strong></p>
<p>Indications for treatment</p>
<ul>
<li><p>70% stenosis and associated symptoms or deficit</p></li>
<li><p>Lesion with ipsilateral ICA requiring treatment</p></li>
<li><p>Pre-occlusive lesion in a good surgical candidate (&gt;5y life expectancy)</p></li>
</ul>
<p>Innominate or SCA Occlusive Disease</p>
<ul>
<li><p>Endovascular with balloon expandable stent via femoral or ipsilateral brachial artery. <span class="citation" data-cites="chatterjeeAngioplastyAloneAngioplasty2013 bradaricEndovascularTherapyStenoOcclusive2015 sahaSubclavianArteryDisease2017 palchik2008 mordasini2011">(<a href="references.html#ref-chatterjeeAngioplastyAloneAngioplasty2013" role="doc-biblioref">Chatterjee et al. 2013</a>; <a href="references.html#ref-bradaricEndovascularTherapyStenoOcclusive2015" role="doc-biblioref">Bradaric et al. 2015</a>; <a href="references.html#ref-sahaSubclavianArteryDisease2017" role="doc-biblioref">Saha et al. 2017</a>; <a href="references.html#ref-palchik2008" role="doc-biblioref">Palchik et al. 2008</a>; <a href="references.html#ref-mordasini2011" role="doc-biblioref">Mordasini et al. 2011</a>)</span> Preferred in:</p>
<ul>
<li><p>Short segment or ostial disease with adequate distance to the vertebral artery origin.</p></li>
<li><p>History of neck surgery or radiation.</p></li>
</ul></li>
<li><p>Surgery:</p>
<ul>
<li><p>Bypass from aortic arch through median sternotomy - Most durable option, particularly for dense R innominate disease, so preferred in patients who can tolerate. Endarterectomy not appropriate if disease involves the origin.<span class="citation" data-cites="aiello2011 mansukhani2018 berguer1998 daniel2014 reul1991 berguer1999 byrne2007">(<a href="references.html#ref-aiello2011" role="doc-biblioref">Aiello and Morrissey 2011</a>; <a href="references.html#ref-mansukhani2018" role="doc-biblioref">Mansukhani et al. 2018</a>; <a href="references.html#ref-berguer1998" role="doc-biblioref">Berguer, Morasch, and Kline 1998</a>; <a href="references.html#ref-daniel2014" role="doc-biblioref">Daniel et al. 2014</a>; <a href="references.html#ref-reul1991" role="doc-biblioref">Reul et al. 1991</a>; <a href="references.html#ref-berguer1999" role="doc-biblioref">Berguer et al. 1999</a>; <a href="references.html#ref-byrne2007" role="doc-biblioref">Byrne et al. 2007</a>)</span></p>
<ul>
<li>Complications include compression of the graft on sternal closure, so proximal anastomosis should be placed to the side of the aorta.</li>
</ul></li>
<li><p>Ipsilateral CCA to subclavian artery (bypass or transposition) - Recent NSQIP study showed no difference in stroke and death for CS bypass vs transposition, therefore procedure should be determined by anatomic constraints.<span class="citation" data-cites="cinà2002 vandervliet1995">(<a href="references.html#ref-cinà2002" role="doc-biblioref">Cinà et al. 2002</a>; <a href="references.html#ref-vandervliet1995" role="doc-biblioref">Vliet et al. 1995</a>)</span> Small studies and systematic reviews have shown that patency of carotid subclavian bypass is better with synthetic graft than with autologous vein.<span class="citation" data-cites="aburahma2000 illuminati2018 ziomek1986">(<a href="references.html#ref-aburahma2000" role="doc-biblioref">AbuRahma, Robinson, and Jennings 2000</a>; <a href="references.html#ref-illuminati2018" role="doc-biblioref">Illuminati et al. 2018</a>; <a href="references.html#ref-ziomek1986" role="doc-biblioref">Ziomek et al. 1986</a>)</span></p>
<ul>
<li><p>An additional indication for carotid subclavian bypass is as a staged revascularization prior to TEVAR for aneurysmal disease requiring coverage of the LSA</p></li>
<li><p><strong>How does the exposure differentiate in transposition vs bypass?</strong></p>
<ul>
<li><p>Arterial transposition via a short, transverse cervical incision above the clavicle between two heads of SCM (bypass is lateral to entire SCM)</p></li>
<li><p>Sub-platysmal flaps created and avoid EJ vein damage</p></li>
<li><p>Omohypoid divided between heads of SCM and IJ mobilized laterally (bypass IJ is mobilized medially to expose CCA and care must be taken to avoid phrenic nerve in more lateral approach)</p></li>
<li><p>CCA is reflected medially with vagus nerve</p></li>
<li><p>On the left side, the thoracic duct is identifiable and divided followed by dividing the vertebral vein</p></li>
<li><p>Subclavian artery and proximal branches identified (anterior scalene is in lateral dissection)</p></li>
</ul></li>
<li><p><strong>What are some common complications after carotid subclavian bypass in order of highest to lowest incidence?</strong></p>
<ol type="1">
<li><p>Phrenic nerve palsy (most common) - most often managed conservatively.</p></li>
<li><p>Recurrent laryngeal palsy</p></li>
<li><p>Lymphatic leak</p></li>
<li><p>Neck hematoma<span class="citation" data-cites="voigtOutcomesCarotidsubclavianBypass2019">(<a href="references.html#ref-voigtOutcomesCarotidsubclavianBypass2019" role="doc-biblioref">Voigt et al. 2019</a>)</span></p></li>
</ol></li>
<li><p><strong>When carotid-subclavian bypass compared to transposition?</strong></p>
<ol type="1">
<li><p>Vertebral artery takes origin from the subclavian artery in a very proximal position or is dominant over the contralateral side, then bypass preferred. <span class="citation" data-cites="moraschTechniqueSubclavianCarotid2009d">(<a href="references.html#ref-moraschTechniqueSubclavianCarotid2009d" role="doc-biblioref">Morasch 2009</a>)</span></p></li>
<li><p>For coronary-subclavian steal with patent internal mammary artery to coronary artery bypass graft, then Bypass (a carotid-subclavian transposition requires a more proximal clamp with occlusion of inline antegrade flow to the coronary bypass during the procedure) <span class="citation" data-cites="cuaReviewCoronarySubclavian2017">(<a href="references.html#ref-cuaReviewCoronarySubclavian2017" role="doc-biblioref">Cua et al. 2017</a>)</span></p></li>
</ol></li>
</ul></li>
<li><p>Contralateral CCA (anterior or retropharyngeal)</p></li>
</ul></li>
</ul>
<p>Brachial/forearm Occlusive disease</p>
<ul>
<li><p>Endovascular: PTA evidence is anecdotal with stents for lesions unresponsive to PTA or dissection following angioplasty.<span class="citation" data-cites="cheun2019 nasser2014 dineen2007">(<a href="references.html#ref-cheun2019" role="doc-biblioref">Cheun et al. 2019</a>; <a href="references.html#ref-nasser2014" role="doc-biblioref">Nasser et al. 2014</a>; <a href="references.html#ref-dineen2007" role="doc-biblioref">Dineen, Smith, and Arko 2007</a>)</span></p></li>
<li><p>Surgery: GSV vein bypass remains standard for revascularization with bypasses to superficial or deep palmar arch have good patency rates. Tunneling is subcutaneous if to distal ulnar or superficial palmar arch whereas anatomical to distal radial artery over the anatomic snuffbox.<span class="citation" data-cites="chang2003 masden2012 spinelli2010">(<a href="references.html#ref-chang2003" role="doc-biblioref">B. B. Chang et al. 2003</a>; <a href="references.html#ref-masden2012" role="doc-biblioref">Masden, Seruya, and Higgins 2012</a>; <a href="references.html#ref-spinelli2010" role="doc-biblioref">Spinelli et al. 2010</a>)</span></p></li>
</ul>
</section>
</section>
</section>
<section id="vasospastic-disorders" class="level2" data-number="3.3">
<h2 data-number="3.3" class="anchored" data-anchor-id="vasospastic-disorders"><span class="header-section-number">3.3</span> Vasospastic Disorders</h2>
<section id="iatrogenic-or-vasopressor-induced-ischemia" class="level3" data-number="3.3.1">
<h3 data-number="3.3.1" class="anchored" data-anchor-id="iatrogenic-or-vasopressor-induced-ischemia"><span class="header-section-number">3.3.1</span> Iatrogenic or Vasopressor Induced Ischemia</h3>
<p><strong>You are called to the intensive care unit for a septic patient with acute bilateral upper limb ischemia, what is the management strategy?</strong></p>
<p>Critically ill patients on vasopressors with bilateral upper extremity ischemia are often managed best with supportive measures and attempts to wean vasopressors (especially norepinephrine).<span class="citation" data-cites="landry2018">(<a href="references.html#ref-landry2018" role="doc-biblioref">Gregory J. Landry et al. 2018</a>)</span></p>
<p>Limited role for radial artery embolectomy, only in clear ischemia isolated to the distribution of an occluded radial artery, often secondary to line placement.<span class="citation" data-cites="valentine2005">(<a href="references.html#ref-valentine2005" role="doc-biblioref">Valentine, Modrall, and Clagett 2005</a>)</span></p>
</section>
<section id="raynauds-phenomenon" class="level3" data-number="3.3.2">
<h3 data-number="3.3.2" class="anchored" data-anchor-id="raynauds-phenomenon"><span class="header-section-number">3.3.2</span> Raynaud’s Phenomenon</h3>
<p><strong>What is Raynaud’s and what causes it?</strong> <span class="citation" data-cites="shuja117UpperExtremity landry141RaynaudPhenomenon2019">(<a href="references.html#ref-shuja117UpperExtremity" role="doc-biblioref">Shuja, n.d.</a>; <a href="references.html#ref-landry141RaynaudPhenomenon2019" role="doc-biblioref">Gregory J. Landry 2019</a>)</span></p>
<p>Exaggeration of normal physiologic response with episodic pallor or cyanosis of the fingers caused by small digital artery vasoconstriction occurring in response to cold or emotional stress. There is an abnormality with sympathetic nervous system, resulting in a multifactorial problem involving a combination of vascular, neural, and humoral factors.</p>
<p><strong>What are the subtypes of Raynaud’s phenomenon and what is the underlying pathology?</strong></p>
<ol type="1">
<li><p>Primary: Raynaud’s disease-idiopathic form that is a benign process not associated with structural vascular change. Triggers include (cold, emotional stress, caffeine) resulting in digital smooth muscle contraction and temporary digital hypoperfusion.</p></li>
<li><p>Secondary: Fixed vascular obstruction to blood flow decreasing threshold for cold induced vasospasm or progress to tissue loss. Diseases associated include mixed connective tissue disease, SLE, and rheumatoid arthritis, and scleroderma (accounts for 80-90% of cases). In setting of lower digital blood pressure, symptomatic digital ischemia or tissue loss under low stress conditions. With cold/emotional stress, vasoconstrictive response of digital artery smooth muscle further causes arterial closure and resultant symptoms</p></li>
</ol>
<p><strong>What are diagnostic criteria for Raynaud’s?</strong></p>
<ul>
<li><p>Clinical (Progression of ischemia with white -&gt; blue -&gt; red finger discoloration. Episodes can be self-limited and may last from less than a minute, but generally not longer than 10-20 minutes</p></li>
<li><p>Qualitative testing for severity of cold sensitivity in Raynaud’s syndrome can be useful. Most basic test is cold sensitivity and recovery after ice water immersion. &gt;10 minutes return to baseline pressure concerning for Raynaud’s</p></li>
<li><p>Segmental pressures with finger systolic blood pressure can differentiate purely vasospastic vs occlusive disease. Difference of more than 15 mm Hg between fingers or absolute finger pressure &lt;70 mm Hg may indicate occlusive disease</p></li>
<li><p>Serologic evaluation (ANA/RF)</p></li>
</ul>
<p><strong>What are appropriate treatments for Raynaud’s phenomenon?</strong></p>
<ol type="1">
<li><p>Medical-cold/tobacco avoidance lead to improvement in around half of patients. Calcium channel blocker (nifedipine ER 30mg qday) and losartan (50mg BID) have been shown to be most effective.<span class="citation" data-cites="landry2013 wigley2016">(<a href="references.html#ref-landry2013" role="doc-biblioref">Gregory J. Landry 2013</a>; <a href="references.html#ref-wigley2016" role="doc-biblioref">Wigley and Flavahan 2016</a>)</span> Other drugs include alpha blocker, sildenafil, fluoxetine (SSRI), reserpine, cilostazol, captopril.</p>
<ul>
<li>OUTCOMES ARE POOR IN PATIENTS WITH ARTERIAL OBSTRUCTION. If there is an asymmetric vascular examination, then further non-invasive vascular imaging is needed.</li>
</ul></li>
<li><p>Surgical-thoracic sympathectomy (used for treatment of digital artery vasospasm/digital ischemic ulceration). For vasospasm, thoracic sympathectomy is initially successful, but symptoms return generally within 3-6 months.</p></li>
<li><p>Immunosuppression/immunomodulation for connective tissue disorders associated with secondary Raynaud phenomenon</p></li>
</ol>
<p>See Landry’s Review in JVS for a good treatment algorithm.<span class="citation" data-cites="landry2013">(<a href="references.html#ref-landry2013" role="doc-biblioref">Gregory J. Landry 2013</a>)</span></p>
</section>
<section id="ergotism" class="level3" data-number="3.3.3">
<h3 data-number="3.3.3" class="anchored" data-anchor-id="ergotism"><span class="header-section-number">3.3.3</span> Ergotism</h3>
<p><strong>What is Ergotism?</strong> <span class="citation" data-cites="jamescstanleyCurrentTherapyVascular2014">(<a href="references.html#ref-jamescstanleyCurrentTherapyVascular2014" role="doc-biblioref">Stanley, Veith, and Wakefield 2014</a>)</span></p>
<ul>
<li><p>Etiology: Ergot is a parasitic fungal disease that has a particular prevalence for infecting rye plants and ergot alkaloids have been linked to epidemic poisonings that manifested as ergotism from consumption of rye</p></li>
<li><p>Modern day is rare</p></li>
</ul>
<p><strong>What causes Ergotism and how do patients present?</strong></p>
<ul>
<li><p>Ergotamine is chemically like endogenous catecholamines/indolamines and when applied clinically, it behaves as an agonist to alpha-adrenergic, sertoninergic, and dopaminergic receptors. Despite limited bioavailability, vasocontrictive effects have been reported to last for 24 hours or longer</p></li>
<li><p>Gangrenous-mild limb pain followed by burning pain/shooting and</p></li>
<li><p>Convulsive-heaviness in limbs and head associated with diarrhea. Could result in tonic-clonic spasms</p></li>
</ul>
<p><strong>How can you diagnose Ergotism and what is the process for treating this disease?</strong></p>
<p>Upper extremity ischemia (i.e.&nbsp;digital ulceration) in the setting of ergot alkaloid use (typically for migraines). The treatment includes:</p>
<ul>
<li><p>Volume expansion and IV heparin as anticoagulation</p></li>
<li><p>IV infusion of nitroprusside, nitroglycerin, iloprost or combination</p></li>
<li><p>Infusion of Ca 2+ channel blockers</p></li>
<li><p>Surgical: for thrombosis, consider thrombolysis</p></li>
</ul>
</section>
<section id="buergers-disease" class="level3" data-number="3.3.4">
<h3 data-number="3.3.4" class="anchored" data-anchor-id="buergers-disease"><span class="header-section-number">3.3.4</span> Buerger’s Disease</h3>
<p><strong>How is Buerger’s disease categorized?</strong></p>
<p>Non-atherosclerotic, segmental, inflammatory disease of small/medium sized arteries in distal extremities of tobacco users distinct from either atherosclerosis of immune arteritis<span class="citation" data-cites="jacklcronenwettVascularDecisionMaking2020 lejoncour2018">(<a href="references.html#ref-jacklcronenwettVascularDecisionMaking2020" role="doc-biblioref">Jack L Cronenwett, Alik Farber, and Erica L. Mitchell 2020</a>; <a href="references.html#ref-lejoncour2018" role="doc-biblioref">Le Joncour et al. 2018</a>)</span></p>
<p><strong>What clinical criteria can help diagnose Buerger’s?</strong></p>
<p>Smoking history, onset before 50 years, infrapopliteal arterial occlusions, upper limb involvement, absence of atherosclerotic risk factors besides smoking</p>
<p><strong>What is important about diagnosing Buerger’s</strong></p>
<ul>
<li><p>Typically a diagnosis of exclusion</p></li>
<li><p>Must rule out proximal embolic source, trauma, local lesions (e.g.&nbsp;pop entrapment or cystic adventitial disease), autoimmune disease, hypercoagulable status, atherosclerosis</p></li>
</ul>
<p><strong>What physical exam and non-invasive/invasive imaging findings of Buerger’s?</strong></p>
<ul>
<li><p>Distal, but not proximal arterial disease (palpable brachial/popliteal but absent/reduced at ankle or wrist)</p></li>
<li><p>DBI&lt;0.6 and flat/reduced digital waveforms</p></li>
<li><p>CTA/MRA/DSA or duplex - characteristic findings of serpiginous/corkscrew collaterals, occlusion of distal calf/pedal arteries, and normal proximal arteries.<span class="citation" data-cites="busch2011 fujii2011">(<a href="references.html#ref-busch2011" role="doc-biblioref">Busch 2011</a>; <a href="references.html#ref-fujii2011" role="doc-biblioref">Fujii et al. 2011</a>)</span></p></li>
</ul>
<p><strong>What is the mainstay treatment in Buerger’s disease?</strong></p>
<ol type="1">
<li><p>Smoking cessation! Only treatment to improve symptoms and reduce amputation risk if achieved before onset of gangrene or tissue loss. Important to remember following treatments will likely fail without smoking cessation.</p></li>
<li><p>If smoking cessation does not improve, medical management with antiplatelet agents, immunomodulators, vasodilators, anticoagulants</p></li>
<li><p>Endovascular-distal small vessel intervention</p></li>
<li><p>Surgical-upper extremity autogenous vein bypass-limited success due to poor outflow</p></li>
<li><p>Sometimes can consider upper extremity sympathectomy, but unproven benefit</p></li>
<li><p>Amputation-reported in 30-40% who are followed longer than 5 years<span class="citation" data-cites="olin2018">(<a href="references.html#ref-olin2018" role="doc-biblioref">Olin 2018</a>)</span></p></li>
</ol>
</section>
<section id="large-vasculitis" class="level3" data-number="3.3.5">
<h3 data-number="3.3.5" class="anchored" data-anchor-id="large-vasculitis"><span class="header-section-number">3.3.5</span> Large Artery Vasculitis</h3>
<p><strong>What are common characteristics for patients who are suspected to have a large vessel vasculitis?</strong> <span class="citation" data-cites="shanmugam137VasculitisOther2019 weyand2003">(<a href="references.html#ref-shanmugam137VasculitisOther2019" role="doc-biblioref">Shanmugam 2019a</a>; <a href="references.html#ref-weyand2003" role="doc-biblioref">Weyand and Goronzy 2003</a>)</span></p>
<ul>
<li><p>Affect aorta and major branches</p></li>
<li><p>Present with non-specific heterogenous symptoms making the diagnosis challenging. Most commonly, they present with systemic or constitutional symptoms (fatigue, fever, weight loss, arthralgias)</p></li>
<li><p>Frequently, diagnosis made with presence of constitutional symptoms, elevated inflammatory markers, and dedicated imaging (MRA, CTA, DUS, or PET)</p></li>
</ul>
<p><strong>How can you differentiate Takayasu arteritis vs giant cell arteritis?</strong></p>
<section id="takayasu-arteritis" class="level4" data-number="3.3.5.1">
<h4 data-number="3.3.5.1" class="anchored" data-anchor-id="takayasu-arteritis"><span class="header-section-number">3.3.5.1</span> Takayasu arteritis</h4>
<ol type="1">
<li><p>Aorta and primary<span class="citation" data-cites="ehlert2019">(<a href="references.html#ref-ehlert2019" role="doc-biblioref">Ehlert and Abularrage 2019</a>)</span></p></li>
<li><p>Young patients &lt;20 years and female in 80-90% of cases, Asian populations</p></li>
<li><p>Criteria (ACR)</p>
<ol type="1">
<li><p>Onset &lt;40 years</p></li>
<li><p>Claudication of an extremity</p></li>
<li><p>Decreased brachial pulse</p></li>
<li><p>&gt;10 mmHg SBP between arms</p></li>
<li><p>Bruit over subclavian arteries or aorta</p></li>
<li><p>Arteriographic evidence of narrowing/occlusion in aorta/primary branches/or large upper/lower extremity arteries</p></li>
</ol></li>
<li><p>Initial therapy for acute vasculitis should include steroids and close observation. If persistent severe symptoms after acute phase, then consider surgical repair. Mid aortic syndrome likely needs open repair from uninvolved aorta-usually thoracic aorta-to bifurcation bypass with jump graft to involved visceral vessels.<span class="citation" data-cites="ehlert2019">(<a href="references.html#ref-ehlert2019" role="doc-biblioref">Ehlert and Abularrage 2019</a>)</span></p></li>
</ol>
</section>
<section id="giant-cell-arteritis" class="level4" data-number="3.3.5.2">
<h4 data-number="3.3.5.2" class="anchored" data-anchor-id="giant-cell-arteritis"><span class="header-section-number">3.3.5.2</span> Giant cell arteritis</h4>
<ol type="1">
<li><p>Aorta and main branches, but predilection for carotid artery branches<span class="citation" data-cites="bongartz2006">(<a href="references.html#ref-bongartz2006" role="doc-biblioref">Bongartz and Matteson 2006</a>)</span></p></li>
<li><p>Diagnosis:</p>
<ol type="1">
<li><p>Age at disease onset &gt; 50 years</p></li>
<li><p>New headache</p></li>
<li><p>Temporal artery abnormality</p></li>
<li><p>Elevated ESR (&gt;50) - can be normal in up to a quarter of cases.</p></li>
<li><p>Abnormal artery biopsy (gold standard test)</p></li>
</ol></li>
<li><p>Other symptoms include jaw pain with mastication or visual changes</p></li>
<li><p>Associated with Polymyalgia rheumatic, characterized by morning stiffness in shoulders/hips occurring in 40-50% of patients</p></li>
<li><p>Arteriography/MRA/CTA/PET may be used to assess large vessel involvement - classic finding is smooth, tapering stenosis.</p></li>
</ol>
<p><strong>How should patients be monitored with active large artery vasculitis?</strong></p>
<ul>
<li><p>Lab data tracked at least monthly for 6 months with close follow-up to ensure appropriate response to medical treatment and enable physicians to assess for adverse effects of medical treatment</p></li>
<li><p>Repeat tests after remission reached and imaging choice to evaluate large vessels (DUS/CTA/MRA)</p></li>
</ul>
<p><strong>What is the medical treatment for GCA and when do you consider surgical treatment?</strong></p>
<ul>
<li><p>Medical-steroid therapy. In as many as 50% of patients who have a large vessel vasculitis refractory to glucocorticoid therapy alone, patients will trial immunomodulators or cytotoxic trugs (i.e.&nbsp;methotrexate, azathioprine, mycophenolate, tocilizumab, or leflunomide)</p></li>
<li><p>Intervention-once remission, treatment of symptomatic arterial lesions or those at aneurysm size threshold should be considered and as many as 50-70% with large vessel vasculitis will require intervention.</p>
<ul>
<li><p>Endovascular-angioplasty/stent/stent graft for large vessel vasculitis have all been described, however higher restenosis in endovascular compared to open treatment</p></li>
<li><p>Open Surgery (gold standard)-lesions are long, fibrotic and therefore less amenable to endovascular treatment. Bypass grafts from aorta-CCA are the most common (CEA should be avoid due to pathology involved)</p>
<ul>
<li><p>Upper extremity bypass with autogenous vein to the brachial artery</p></li>
<li><p>Aortic aneurysms should be managed with open surgery<span class="citation" data-cites="janssen2008">(<a href="references.html#ref-janssen2008" role="doc-biblioref">Janssen et al. 2008</a>)</span></p></li>
</ul></li>
</ul></li>
</ul>
</section>
</section>
<section id="other-vasculitis-syndromes" class="level3" data-number="3.3.6">
<h3 data-number="3.3.6" class="anchored" data-anchor-id="other-vasculitis-syndromes"><span class="header-section-number">3.3.6</span> Other Vasculitis syndromes</h3>
<p>Polyarteritis Nodosum - Focal necrotizing lesions primarily affecting medium-sized muscular arteries, peak incidence in 40s.&nbsp; Multiple saccular aneurysms secondary to inflammatory destruction of vessel media.<span class="citation" data-cites="shanmugam2019 weyand2003">(<a href="references.html#ref-shanmugam2019" role="doc-biblioref">Shanmugam 2019b</a>; <a href="references.html#ref-weyand2003" role="doc-biblioref">Weyand and Goronzy 2003</a>)</span></p>
<p>Behçet Disease - recurrent oral pathos ulcers, genital ulcers and uveitis.<span class="citation" data-cites="shanmugam2019 weyand2003">(<a href="references.html#ref-shanmugam2019" role="doc-biblioref">Shanmugam 2019b</a>; <a href="references.html#ref-weyand2003" role="doc-biblioref">Weyand and Goronzy 2003</a>)</span></p>
</section>
</section>
<section id="aneurysmal-disease" class="level2" data-number="3.4">
<h2 data-number="3.4" class="anchored" data-anchor-id="aneurysmal-disease"><span class="header-section-number">3.4</span> Aneurysmal Disease</h2>
<section id="subclavian-artery-aneurysms" class="level3" data-number="3.4.1">
<h3 data-number="3.4.1" class="anchored" data-anchor-id="subclavian-artery-aneurysms"><span class="header-section-number">3.4.1</span> Subclavian Artery Aneurysms</h3>
<p><strong>How are subclavian aneurysms caused and how can they present?</strong> <span class="citation" data-cites="baig84UpperExtremity2019">(<a href="references.html#ref-baig84UpperExtremity2019" role="doc-biblioref">Baig and Timaran 2019</a>)</span></p>
<section id="etiology" class="level4" data-number="3.4.1.1">
<h4 data-number="3.4.1.1" class="anchored" data-anchor-id="etiology"><span class="header-section-number">3.4.1.1</span> Etiology</h4>
<ul>
<li><p>Degenerative - atherosclerotic or due to aberrant right subclavian with degenerative changes in proximal subclavian known as “Kommerell diverticulum”</p></li>
<li><p>Traumatic - blunt, penetrating, iatrogenic with attempted catheter placement</p></li>
<li><p>Radiation induced, sometimes seen after radiation for breast cancer.<span class="citation" data-cites="mohan2016">(<a href="references.html#ref-mohan2016" role="doc-biblioref">Mohan et al. 2016</a>)</span></p></li>
<li><p>Thoracic outlet obstruction - no need to investigate for aTOS if there is another plausible cause.</p></li>
</ul>
</section>
<section id="presentation" class="level4" data-number="3.4.1.2">
<h4 data-number="3.4.1.2" class="anchored" data-anchor-id="presentation"><span class="header-section-number">3.4.1.2</span> Presentation</h4>
<ul>
<li>Rare, comprises 1% of peripheral aneurysms.</li>
<li>Exam-pulsatile supraclavicular mass or bruit, absent/diminished pulses, signs of microembolization (“blue finger”)</li>
<li>Most discovered incidentally, however referred chest, neck, shoulder pain, upper extremity ischemia due to thrombosis or distal embolism, brachial plexus compression, hoarseness from right recurrent laryngeal nerve compression</li>
<li>Dysphagia from esophageal compression in aberrant right subclavian artery</li>
<li>Rarely rupture</li>
</ul>
</section>
<section id="evaluation-1" class="level4" data-number="3.4.1.3">
<h4 data-number="3.4.1.3" class="anchored" data-anchor-id="evaluation-1"><span class="header-section-number">3.4.1.3</span> Evaluation</h4>
<p><strong>What are diagnostic studies and treatment modalities for subclavian aneurysms?</strong></p>
<ul>
<li><p>CXR-mediastinal mass may suggest neoplasm</p></li>
<li><p>MRA/CTA important to delineate extent of aneurysm and proximity to ipsilateral vertebral artery</p></li>
</ul>
</section>
<section id="management-1" class="level4" data-number="3.4.1.4">
<h4 data-number="3.4.1.4" class="anchored" data-anchor-id="management-1"><span class="header-section-number">3.4.1.4</span> Management</h4>
<ul>
<li><p>Open Repair-resection/endoaneurysmorrhaphy with end to end (small aneurysms) or interposition prosthetic graft<span class="citation" data-cites="vierhout2010">(<a href="references.html#ref-vierhout2010" role="doc-biblioref">Vierhout et al. 2010</a>)</span></p>
<ul>
<li><p>Proximal-median sternotomy with supraclavicular fossa extension for adequate proximal control for right side, however supraclavicular with left anterolateral thoracotomy for left subclavian aneurysm</p></li>
<li><p>Mid-Distal-supraclavicular/infraclavicular generally adequate for control where again resection of the clavicle may be needed</p></li>
</ul></li>
<li><p>Endovascular Repair-transbrachial/transfemoral approach with covered stent<span class="citation" data-cites="maskanakis2018">(<a href="references.html#ref-maskanakis2018" role="doc-biblioref">Maskanakis et al. 2018</a>)</span></p>
<ul>
<li>Must consider vertebral artery origin. Can cover vertebral artery if contralateral vertebral artery is patent and of adequate size, however posterior circulation stroke may occur when the contralateral vertebral artery is highly stenotic, hypoplastic or occluded.</li>
</ul></li>
<li><p>Hybrid Repair-embolization/coils of proximal subclavian artery combined with subclavian transposition or carotid-subclavian bypass</p></li>
<li><p>For aberrant subclavian artery aneurysm, resection or exclusion of the aneurysmal artery with vascular reconstruction of the subclavian artery is recommended. Especially in the setting of dysphagia lusoria, subclavian artery reconstructed by interposition graft where proximal anastomosis is on ascending aorta. Alternatively, left posterolateral thoracotomy for proximal aneurysm resection and right supraclavicular incision for reconstruction of subclavian artery by end to side to the right CCA has been reported.</p></li>
</ul>
</section>
</section>
<section id="axillary-artery-aneurysms" class="level3" data-number="3.4.2">
<h3 data-number="3.4.2" class="anchored" data-anchor-id="axillary-artery-aneurysms"><span class="header-section-number">3.4.2</span> Axillary Artery Aneurysms</h3>
<p><strong>How are axillary aneurysms caused and how can they present?</strong></p>
<section id="etiology-1" class="level4" data-number="3.4.2.1">
<h4 data-number="3.4.2.1" class="anchored" data-anchor-id="etiology-1"><span class="header-section-number">3.4.2.1</span> Etiology</h4>
<ul>
<li><p>Blunt/penetrating trauma</p></li>
<li><p>Congenital (infrequently reported)</p></li>
<li><p>Post-traumatic axillary aneurysms (repeated abduction/external rotation downward toward humeral head in baseball pitchers)</p></li>
</ul>
</section>
<section id="presentation-1" class="level4" data-number="3.4.2.2">
<h4 data-number="3.4.2.2" class="anchored" data-anchor-id="presentation-1"><span class="header-section-number">3.4.2.2</span> Presentation</h4>
<ul>
<li>Exam-pulsatile supraclavicular mass or bruit, absent/diminished pulses, signs of microembolization (“blue finger”)</li>
</ul>
<p><strong>What are diagnostic studies and treatment modalities for axillary aneurysms?</strong></p>
</section>
<section id="evaluation-2" class="level4" data-number="3.4.2.3">
<h4 data-number="3.4.2.3" class="anchored" data-anchor-id="evaluation-2"><span class="header-section-number">3.4.2.3</span> Evaluation</h4>
<ul>
<li><p>Ultrasound</p></li>
<li><p>CTA/MRA of upper extremity</p></li>
</ul>
</section>
<section id="management-2" class="level4" data-number="3.4.2.4">
<h4 data-number="3.4.2.4" class="anchored" data-anchor-id="management-2"><span class="header-section-number">3.4.2.4</span> Management</h4>
<ul>
<li><p>Open Repair-resection with interposition vein grafting or prosthetic if inadequate vein is present.</p></li>
<li><p>Endovascular repair-covered stent graft can be placed with occasional embolization with micro coils to isolate sac and prevent retrograde endoleaks</p></li>
</ul>
</section>
</section>
<section id="brachial-artery-aneurysms" class="level3" data-number="3.4.3">
<h3 data-number="3.4.3" class="anchored" data-anchor-id="brachial-artery-aneurysms"><span class="header-section-number">3.4.3</span> Brachial Artery Aneurysms</h3>
<p><strong>How are brachial aneurysms caused and how can they present?</strong></p>
<section id="etiology-2" class="level4" data-number="3.4.3.1">
<h4 data-number="3.4.3.1" class="anchored" data-anchor-id="etiology-2"><span class="header-section-number">3.4.3.1</span> Etiology</h4>
<ul>
<li><p>False aneurysms secondary to repetitive trauma</p></li>
<li><p>Iatrogenic complications - Seen in 1-3% of brachial artery access - increased risk in older age, female patients, and larger sheaths.<span class="citation" data-cites="treitl2015">(<a href="references.html#ref-treitl2015" role="doc-biblioref">Treitl et al. 2015</a>)</span> More on appropriate access technique can be found in @ref(endovascular)</p></li>
<li><p>IV drug abuse (infected pseudoaneurysms in antecubital fossa)</p></li>
<li><p>Connective tissue disorders (ex. type IV Ehlers danlos)</p></li>
</ul>
</section>
<section id="presentation-2" class="level4" data-number="3.4.3.2">
<h4 data-number="3.4.3.2" class="anchored" data-anchor-id="presentation-2"><span class="header-section-number">3.4.3.2</span> Presentation:</h4>
<ul>
<li><p>Exam: pulsatile mass</p></li>
<li><p>Local pain or symptoms of median nerve compressions</p></li>
<li><p>Hand/digital ischemia from thrombosis/distal embolization</p></li>
</ul>
<p><strong>What are diagnostic studies and treatment modalities for brachial aneurysms?</strong></p>
</section>
<section id="evaluation-3" class="level4" data-number="3.4.3.3">
<h4 data-number="3.4.3.3" class="anchored" data-anchor-id="evaluation-3"><span class="header-section-number">3.4.3.3</span> Evaluation</h4>
<ul>
<li><p>Duplex Ultrasound</p></li>
<li><p>CTA/MRA of upper extremity may be needed to delineate extent of aneurysm</p></li>
</ul>
</section>
<section id="management-3" class="level4" data-number="3.4.3.4">
<h4 data-number="3.4.3.4" class="anchored" data-anchor-id="management-3"><span class="header-section-number">3.4.3.4</span> Management</h4>
<ul>
<li><p>Open Repair (preferred)-resection with patch or interposition vein grafting</p></li>
<li><p>Endovascular repair-rare and generally in a traumatic setting</p></li>
<li><p>Iatrogenic injuries-due to access and nonoperative treatment for small/asymptomatic pseudoaneurysms that are likely to thrombose spontaneously. Direct suture repair with evacuation of hematoma is possible. Thrombin injection is less favorable due to location and short neck.</p></li>
<li><p>Neurologic symptoms often from median nerve compression an require urgent repair, open surgery best for decompression.</p></li>
</ul>
</section>
</section>
<section id="radial-artery-pseudoaneurysm" class="level3" data-number="3.4.4">
<h3 data-number="3.4.4" class="anchored" data-anchor-id="radial-artery-pseudoaneurysm"><span class="header-section-number">3.4.4</span> Radial Artery Pseudoaneurysm</h3>
<p><strong>How do you manage a patient who presents with a radial artery pseudoaneurysm after a coronary angiogram on year ago?</strong></p>
<p>Small pseudoaneurysms &lt;3cm have a high rate of spontaneous thrombosis. However, larger psuedoaneurysms or those with symptoms require treatment. Often best managed with open excision and primary repair or interposition graft.<span class="citation" data-cites="tosti2017">(<a href="references.html#ref-tosti2017" role="doc-biblioref">Tosti et al. 2017</a>)</span></p>
<p>Can also be seen as a result of trauma.<span class="citation" data-cites="bagir2017">(<a href="references.html#ref-bagir2017" role="doc-biblioref">Bagir, Sayit, and Tanrivermis Sayit 2017</a>)</span></p>
</section>
</section>
<section id="occupational-vascular-disease" class="level2" data-number="3.5">
<h2 data-number="3.5" class="anchored" data-anchor-id="occupational-vascular-disease"><span class="header-section-number">3.5</span> Occupational Vascular Disease</h2>
<p><strong>There are some occupational vascular disorders than contribute to vascular disease in the upper extremity. Hand arm vibration syndrome and hypothenar hammer are of particular importance. Can you talk to us about the key information from these syndromes?</strong> <span class="citation" data-cites="eskandari185ConditionsArising2020">(<a href="references.html#ref-eskandari185ConditionsArising2020" role="doc-biblioref">Eskandari and Morgan 2020</a>)</span></p>
<section id="hand-arm-vibration-syndrome" class="level3" data-number="3.5.1">
<h3 data-number="3.5.1" class="anchored" data-anchor-id="hand-arm-vibration-syndrome"><span class="header-section-number">3.5.1</span> Hand-Arm Vibration Syndrome</h3>
<section id="etiology-3" class="level4" data-number="3.5.1.1">
<h4 data-number="3.5.1.1" class="anchored" data-anchor-id="etiology-3"><span class="header-section-number">3.5.1.1</span> Etiology</h4>
<ul>
<li><p>Vibrating handheld machines (eg pneumatic hammers and drills, grinders, and chain saws)</p></li>
<li><p>Linear relationship between exposure over years and onset of this syndrome</p></li>
<li><p>Exact mechanism unknown, but thought that endothelial damage with sympathetic hyperactivity -&gt; finger blanching attack</p></li>
</ul>
</section>
<section id="presentation-3" class="level4" data-number="3.5.1.2">
<h4 data-number="3.5.1.2" class="anchored" data-anchor-id="presentation-3"><span class="header-section-number">3.5.1.2</span> Presentation</h4>
<ul>
<li><p>Various stages seen where early results in slight tingling/numbness and lateral, the tips of one or more fingers experience attacks of blanching that is usually precipitated by cold</p></li>
<li><p>Blanching typically lasts 1 hour and terminates with reactive hyperemia, but prolonged exposure can cause bluish black cyanosis of fingers</p></li>
</ul>
</section>
<section id="evaluation-4" class="level4" data-number="3.5.1.3">
<h4 data-number="3.5.1.3" class="anchored" data-anchor-id="evaluation-4"><span class="header-section-number">3.5.1.3</span> Evaluation</h4>
<ul>
<li><p>Detailed history with use of vibrating tools/symptoms of Raynaud phenomenon</p></li>
<li><p>Objectively: cold induced ischemia with recording time until digital temperature recovers</p></li>
<li><p>Digital occlusion with noninvasive digit pressures or duplex scanning</p></li>
</ul>
</section>
<section id="management-4" class="level4" data-number="3.5.1.4">
<h4 data-number="3.5.1.4" class="anchored" data-anchor-id="management-4"><span class="header-section-number">3.5.1.4</span> Management</h4>
<ul>
<li><p>Avoidance of vibratory tools</p></li>
<li><p>Nifedipine (Ca2+ channel blocker) in advanced cases</p></li>
<li><p>IV prostanoid (ie prostacyclin) for digital gangrene</p></li>
<li><p>Surgery-cervical sympathetectomy or digital sympathectomy rarely needed<br>
</p></li>
</ul>
</section>
</section>
<section id="hypothenar-hammer-syndrome" class="level3" data-number="3.5.2">
<h3 data-number="3.5.2" class="anchored" data-anchor-id="hypothenar-hammer-syndrome"><span class="header-section-number">3.5.2</span> Hypothenar hammer syndrome</h3>
<section id="etiology-4" class="level4" data-number="3.5.2.1">
<h4 data-number="3.5.2.1" class="anchored" data-anchor-id="etiology-4"><span class="header-section-number">3.5.2.1</span> Etiology</h4>
<ul>
<li><p>Repetitive use of palm of hand in activities that involve pushing, pounding, twisting - particularly to the ulnar artery as it exits guyots canal and crosses the hook of the hamate.<span class="citation" data-cites="ferris2000">(<a href="references.html#ref-ferris2000" role="doc-biblioref">Ferris et al. 2000</a>)</span></p></li>
<li><p>Name comes from reports of mechanics, factory workers, carpenters or laborers who habitually use there hands as a hammer are ad risk for disease</p></li>
<li><p>Repetitive trauma leads to thrombotic occlusion, aneurysm formation or both</p></li>
</ul>
</section>
<section id="presentation-4" class="level4" data-number="3.5.2.2">
<h4 data-number="3.5.2.2" class="anchored" data-anchor-id="presentation-4"><span class="header-section-number">3.5.2.2</span> Presentation</h4>
<ul>
<li><p>Asymmetrical distribution involving dominant upper extremity where cyanosis and pallor can occur and digits affected are ulnar distribution in nature</p></li>
<li><p>Cool/mottled digits or severe cases with ischemic ulcers</p></li>
</ul>
</section>
<section id="evaluation-5" class="level4" data-number="3.5.2.3">
<h4 data-number="3.5.2.3" class="anchored" data-anchor-id="evaluation-5"><span class="header-section-number">3.5.2.3</span> Evaluation</h4>
<ul>
<li><p>Duplex ultrasound</p></li>
<li><p>CTA or MRA</p></li>
<li><p>Arteriography (gold standard) with corkscrew pattern typically in affected vessels</p></li>
</ul>
</section>
<section id="management-5" class="level4" data-number="3.5.2.4">
<h4 data-number="3.5.2.4" class="anchored" data-anchor-id="management-5"><span class="header-section-number">3.5.2.4</span> Management</h4>
<ul>
<li><p>Conservative-smoking cessation/hand protection/cold avoidance.<span class="citation" data-cites="carr2019">(<a href="references.html#ref-carr2019" role="doc-biblioref">Carr et al. 2019</a>)</span></p></li>
<li><p>Medical-calcium channel blockers/antiplatelet</p></li>
<li><p>Surgical (severe digital ischemia/aneurysm)-ligation if adequate collateral or interposition vein graft has good long term patency.</p></li>
</ul>
</section>
</section>
<section id="environmental-exposures" class="level3" data-number="3.5.3">
<h3 data-number="3.5.3" class="anchored" data-anchor-id="environmental-exposures"><span class="header-section-number">3.5.3</span> Environmental Exposures</h3>
<p><strong>Exposure to what environmental agents can result in upper extremity ischemia?</strong></p>
<p>Acrosteolysis</p>
<ul>
<li><p>Exposure to polyvinyl chloride can result in ischemic hand symptoms similar to those of Raynaud syndrome</p></li>
<li><p>Angiography-damage to digital arteries with multiple stenosis/occlusions or hyper vascularity adjacent to areas of bone resorption</p></li>
<li><p>Treatment-supportive</p></li>
</ul>
<p>Electrical burns</p>
<ul>
<li><p>&lt;1000 V cause injuries limited to immediate skin/soft tissue, however &gt;1000 V cause damage from entry to exit point</p></li>
<li><p>Results in arterial necrosis with thrombus or bleeding and gangrene of digits develop</p></li>
<li><p>Initially can be occlusion/thrombosis or spasm, however later damage can cause aneurysmal degeneration</p></li>
<li><p>Treatment-dependent on soft tissue/bone injuries as well. Can have reconstruction with free flap due to local vascular damage or occlusion of major artery requiring bypass grafting</p></li>
</ul>
<p>Extreme thermal injuries</p>
<ul>
<li><p>Workers at risk with chronic exposure to cold (slaughterhouse, canning factory, and fisheries)</p></li>
<li><p>Raynaud syndrome symptoms due to vasomotor disturbances in the hands when exposed to extreme chronic thermal trauma</p></li>
<li><p>Treatment-Supportive</p></li>
</ul>
</section>
<section id="sports-medicine" class="level3" data-number="3.5.4">
<h3 data-number="3.5.4" class="anchored" data-anchor-id="sports-medicine"><span class="header-section-number">3.5.4</span> Sports Medicine</h3>
<p><strong>How can athletes specifically be affected by upper extremity ischemia?</strong></p>
<p>Athletes who engage in strenuous or exaggerated hand/shoulder activity may be susceptible to upper extremity ischemia from arterial injury manifested by Raynaud syndrome, symptoms of sudden arterial occlusion or digital embolization</p>
</section>
</section>
<section id="vascular-trauma-upper-extremity" class="level2" data-number="3.6">
<h2 data-number="3.6" class="anchored" data-anchor-id="vascular-trauma-upper-extremity"><span class="header-section-number">3.6</span> Vascular Trauma-Upper Extremity</h2>
<p><strong>This is discussed in detail here:</strong> @ref(peripheral), <strong>so we will go over some important specifics for upper extremity vascular injury.</strong> <span class="citation" data-cites="kauvar184VascularTrauma2020">(<a href="references.html#ref-kauvar184VascularTrauma2020" role="doc-biblioref">Kauvar and Kraiss 2020</a>)</span></p>
<section id="subclavian-artery-trauma" class="level3" data-number="3.6.1">
<h3 data-number="3.6.1" class="anchored" data-anchor-id="subclavian-artery-trauma"><span class="header-section-number">3.6.1</span> Subclavian Artery Trauma</h3>
<p><strong>What is the management strategy for an iatrogenic placement of a subclavian artery catheter?</strong></p>
<p>Critically ill patients can be treated effectively with the use of a closure device or covered stent placement.<span class="citation" data-cites="yoon2015 tran2009 cohen2014">(<a href="references.html#ref-yoon2015" role="doc-biblioref">Yoon et al. 2015</a>; <a href="references.html#ref-tran2009" role="doc-biblioref">V. Tran et al. 2009</a>; <a href="references.html#ref-cohen2014" role="doc-biblioref">Cohen et al. 2014</a>)</span> Cut down in the mid subclavian artery is very difficult to perform and results in increased blood loss and worse outcomes.</p>
<p>Trauma to the proximal subclavian should be accessed on R through a median sternotomy or trapdoor incision. On the left, the proximal subclavian is accessed best through an anterolateral thoracotomy. For more on exposures, see @ref(upper-extremity).</p>
</section>
<section id="axillary-artery-trauma" class="level3" data-number="3.6.2">
<h3 data-number="3.6.2" class="anchored" data-anchor-id="axillary-artery-trauma"><span class="header-section-number">3.6.2</span> Axillary Artery Trauma</h3>
<p><strong>What is the mechanism and management of upper extremity axillary artery trauma?</strong></p>
<section id="etiology-5" class="level4" data-number="3.6.2.1">
<h4 data-number="3.6.2.1" class="anchored" data-anchor-id="etiology-5"><span class="header-section-number">3.6.2.1</span> Etiology</h4>
<ul>
<li>Predominantly in penetrating trauma with equal incidence in proximal/middle/distal divisions and brachial plexus injury in &gt;1/3rd of arterial injury</li>
</ul>
</section>
<section id="evaluation-6" class="level4" data-number="3.6.2.2">
<h4 data-number="3.6.2.2" class="anchored" data-anchor-id="evaluation-6"><span class="header-section-number">3.6.2.2</span> Evaluation</h4>
<ul>
<li><p>Physical exam with deficiencies in upper extremity pulses/ischemic changes, but may not be present given collateral flow from axillary artery to upper extremity</p></li>
<li><p>High index of suspicion with location of injury proximity to course of axillary artery</p></li>
<li><p>Upper extremity Doppler or CTA if patient is stable for diagnosis</p></li>
</ul>
</section>
<section id="management-6" class="level4" data-number="3.6.2.3">
<h4 data-number="3.6.2.3" class="anchored" data-anchor-id="management-6"><span class="header-section-number">3.6.2.3</span> Management</h4>
<ul>
<li><p>Primary repair or treated with interposition graft</p></li>
<li><p>If hemodynamically stable, can consider covered stent based on location to thoracic outlet via femoral/brachial approach</p></li>
</ul>
</section>
</section>
<section id="brachial-artery-trauma" class="level3" data-number="3.6.3">
<h3 data-number="3.6.3" class="anchored" data-anchor-id="brachial-artery-trauma"><span class="header-section-number">3.6.3</span> Brachial Artery Trauma</h3>
<p><strong>What is the mechanism and management of upper extremity brachial artery trauma?</strong></p>
<section id="etiology-6" class="level4" data-number="3.6.3.1">
<h4 data-number="3.6.3.1" class="anchored" data-anchor-id="etiology-6"><span class="header-section-number">3.6.3.1</span> Etiology</h4>
<ul>
<li><p>Frequently associated with humerus fractures/elbow dislocation</p></li>
<li><p>Penetrating trauma</p></li>
</ul>
</section>
<section id="evaluation-7" class="level4" data-number="3.6.3.2">
<h4 data-number="3.6.3.2" class="anchored" data-anchor-id="evaluation-7"><span class="header-section-number">3.6.3.2</span> Evaluation</h4>
<ul>
<li><p>Pulse deficit in majority (&gt;75% of cases)</p></li>
<li><p>Upper extremity Doppler of CTA</p></li>
</ul>
</section>
<section id="management-7" class="level4" data-number="3.6.3.3">
<h4 data-number="3.6.3.3" class="anchored" data-anchor-id="management-7"><span class="header-section-number">3.6.3.3</span> Management</h4>
<ul>
<li>Given course, can be extensively mobilized and repaired in end-to-end fashion in 50% of cases. Otherwise, treatment with an interposition graft</li>
</ul>
</section>
</section>
<section id="radialulnar-artery-trauma" class="level3" data-number="3.6.4">
<h3 data-number="3.6.4" class="anchored" data-anchor-id="radialulnar-artery-trauma"><span class="header-section-number">3.6.4</span> Radial/ulnar artery trauma</h3>
<p><strong>What is the mechanism and management of upper extremity radial/ulnar artery trauma?</strong></p>
<section id="etiology-7" class="level4" data-number="3.6.4.1">
<h4 data-number="3.6.4.1" class="anchored" data-anchor-id="etiology-7"><span class="header-section-number">3.6.4.1</span> Etiology</h4>
<ul>
<li>Associated with significant soft tissue pattern</li>
</ul>
</section>
<section id="evaluation-8" class="level4" data-number="3.6.4.2">
<h4 data-number="3.6.4.2" class="anchored" data-anchor-id="evaluation-8"><span class="header-section-number">3.6.4.2</span> Evaluation</h4>
<ul>
<li><p>Pulse deficit in &gt;80% of patients</p></li>
<li><p>Doppler based Allen test-confirm radial/ulnar contribution to palmar arch</p></li>
</ul>
</section>
<section id="management-8" class="level4" data-number="3.6.4.3">
<h4 data-number="3.6.4.3" class="anchored" data-anchor-id="management-8"><span class="header-section-number">3.6.4.3</span> Management</h4>
<ul>
<li><p>If Allen test reveals a patent palmar arch, the injured artery can be ligated</p></li>
<li><p>If palmar arch is not patent in the absence of contribution of the injured artery, it should be repaired</p></li>
<li><p>If both are damaged, preference to ulnar artery as dominant contribution to hand</p></li>
<li><p>Generally, repair can be done in an end to end fashion given mobility of the vessel</p></li>
</ul>
</section>
</section>
</section>
<section id="compression-syndromes" class="level2" data-number="3.7">
<h2 data-number="3.7" class="anchored" data-anchor-id="compression-syndromes"><span class="header-section-number">3.7</span> Compression Syndromes</h2>
<p><strong>The main syndromes are quadrilateral space syndrome and humeral compression of the axillary artery. What important information here do our listeners need to know?</strong></p>
<section id="quadrilateral-space-syndrome" class="level3" data-number="3.7.1">
<h3 data-number="3.7.1" class="anchored" data-anchor-id="quadrilateral-space-syndrome"><span class="header-section-number">3.7.1</span> Quadrilateral space syndrome</h3>
<p>Anatomy</p>
<ul>
<li><p>Bordered by teres minor superiorly, humeral shaft laterally, and teres major inferiorly, and long head of triceps muscle medially</p></li>
<li><p>Posterior humeral circumflex artery and axillary nerve in space</p></li>
</ul>
<p>Etiology</p>
<ul>
<li><p>Compression of posterior humeral circumflex occurs with abduction/external rotation</p></li>
<li><p>Typically seen with chronic overhand motion athletes (pitchers/volleyball players)</p></li>
<li><p>Vascular-repetitive mechanical trauma to posterior circumflex humeral artery</p></li>
<li><p>Neurogenic-fixed structural impaction of quadrilateral space by fibrous bands or space-occupying lesions</p></li>
</ul>
<p>Presentation</p>
<ul>
<li>Muscle atrophy, paresthesias, poorly localized shoulder pain and pain in quadrilateral space</li>
</ul>
<p>Management</p>
<ul>
<li><p>Medical: Oral anti-inflammatory medications, PT, limitation of activities</p></li>
<li><p>Surgery: decompression with neurolysis/excision of fibrous bands or other space occupying lesions</p></li>
</ul>
</section>
<section id="humeral-head-compression-of-axillary-artery" class="level3" data-number="3.7.2">
<h3 data-number="3.7.2" class="anchored" data-anchor-id="humeral-head-compression-of-axillary-artery"><span class="header-section-number">3.7.2</span> Humeral head compression of axillary artery</h3>
<p>Anatomy</p>
<ul>
<li>3rd portion of axillary artery compressed by head of humerus</li>
</ul>
<p>Etiology</p>
<ul>
<li>Arm is abducted and externally rotated with downward compression of humeral head to axillary artery</li>
</ul>
<p>Presentation</p>
<ul>
<li>Arm fatigue, loss of pitch velocity, finger numbness, Raynaud, cutaneous embolization</li>
</ul>
<p>Evaluation</p>
<ul>
<li><p>Provocative maneuvers with impedance of flow through axillary artery on ultrasonography</p></li>
<li><p>Arteriography with rest and provocative position</p></li>
</ul>
<p>TManagement</p>
<ul>
<li><p>Supportive with avoidance of throwing motion</p></li>
<li><p>Surgical-saphenous vein patch for no improvement or structural injury may require resection with saphenous vein bypass anatomically or extra-anatomic tunneling above pec minor</p></li>
</ul>
</section>
</section>
<section id="thoracic-outlet-syndrome" class="level2" data-number="3.8">
<h2 data-number="3.8" class="anchored" data-anchor-id="thoracic-outlet-syndrome"><span class="header-section-number">3.8</span> Thoracic Outlet Syndrome</h2>
<p><strong>27 Nov 2019:</strong> <em>Nedal Katib, Prince of Wales, Sydney Australia</em></p>
<div class="cell">
<div class="cell-output-display">
<audio controls=""> <source src="https://traffic.libsyn.com/audiblebleeding/VSITE_TOS_02auph.mp3" type="audio/mpeg"> Your browser does not support the audio tag;  for browser support, please see:  https://www.w3schools.com/tags/tag_audio.asp </audio>
</div>
</div>
<p>Thoracic Outlet Syndrome = A constellation of signs and symptoms relating to the compression of the neurovascular structures that occurs as these structures travel between the thoracic aperture and the upper limb.</p>
<p>Types: Neurogenic, Venous and Arterial</p>
<ul>
<li><p>vTOS – 2-3%</p></li>
<li><p>aTOS – 1%</p></li>
<li><p>nTOS – &gt;95% <span class="citation" data-cites="humphries124ThoracicOutlet2019">(<a href="references.html#ref-humphries124ThoracicOutlet2019" role="doc-biblioref">Humphries and Freischlag 2019b</a>)</span></p></li>
</ul>
<section id="anatomy-1" class="level3" data-number="3.8.1">
<h3 data-number="3.8.1" class="anchored" data-anchor-id="anatomy-1"><span class="header-section-number">3.8.1</span> Anatomy</h3>
<p>Understanding the anatomy of what is collectively referred to as the thoracic outlet is the best way to thoroughly appreciate this topic.</p>
<p>Anatomy from anterior to posterior</p>
<ul>
<li><p>Subclavian vein</p></li>
<li><p>Phrenic nerve</p></li>
<li><p>Anterior scalene muscle attachment to the first rib</p></li>
<li><p>The subclavian artery</p></li>
<li><p>The brachial plexus</p></li>
<li><p>The middle scalene muscle.</p></li>
</ul>
<p>Three spaces where the neurovascular structures are at risk of compression:</p>
<ol type="1">
<li><p>Interscalene Triangle</p></li>
<li><p>Costoclavicular Passage<span class="citation" data-cites="garygwindAnatomicExposuresVascular2013">(<a href="references.html#ref-garygwindAnatomicExposuresVascular2013" role="doc-biblioref">Gary G Wind and R. James Valentine 2013</a>)</span></p></li>
<li><p>Subcoracoid Space<span class="citation" data-cites="garygwindAnatomicExposuresVascular2013">(<a href="references.html#ref-garygwindAnatomicExposuresVascular2013" role="doc-biblioref">Gary G Wind and R. James Valentine 2013</a>)</span></p></li>
</ol>
<p><strong>Interscalene Triangle:</strong></p>
<p>Appreciating the attachments of the Anterior and Middle Scalene Muscles on the first rib becomes important in the diagnosis of the various types and also the ultimate surgical management of the compression.</p>
<p><strong>Anterior Scalene:</strong></p>
<p>Attachments: Anterior Tubercles of the four ‘typical’ cervical vertebrae (3-6) AND the scalene tubercle on the upper surface of the first rib.</p>
<ul>
<li>Phrenic nerve runs along anterior scalene muscle and injury can cause ipsilateral diaphragm paralysis.</li>
</ul>
<p><strong>Middle Scalene:</strong></p>
<p>Attachments: The posterior tubercles and intertubercular lamellae of all the cervical vertebrae AND the Quadrangular area between the neck and subclavian groove of the first rib. <span class="citation" data-cites="mcminnLastAnatomyRegional2019">(<a href="references.html#ref-mcminnLastAnatomyRegional2019" role="doc-biblioref">McMinn 2019</a>)</span></p>
<ul>
<li>Long thoracic nerve runs along middle scalene muscle and injury can cause winged scapula.</li>
</ul>
<p><strong>The First Rib:</strong></p>
<ul>
<li><p>The broadest and flattest of the ribs and is an ‘Atypical Rib’.</p></li>
<li><p>The upper surface of the first rib has the scalene and quadrangular tubercles for attachments of the anterior and middle scalene muscles respectively. There are also three grooves for the Subclavian Vein, artery and the Lower Trunk of the Brachial Plexus.</p></li>
<li><p>The Inferior Surface is smooth and inferior and medially has an attachment for the suprapleural membrane, Sibson’s fascia AKA scalenus minimus, which is tethered to the C7 vertebrae.</p></li>
<li><p>This is the passage of the subclavian vein largely as it emerges through the tight space created by the clavicle, the subclavius muscle and the costoclavicular ligament and also more posteriorly this can also compress the artery and nerves as the space can also be narrow in relation with the scapula and subscapularis. <span class="citation" data-cites="garygwindAnatomicExposuresVascular2013">(<a href="references.html#ref-garygwindAnatomicExposuresVascular2013" role="doc-biblioref">Gary G Wind and R. James Valentine 2013</a>)</span></p></li>
</ul>
<p><strong>Subclavius Muscle:</strong></p>
<ul>
<li><p>Attached to the costochondral junction of the first rib and is inserted into the subclavian groove on the inferior surface of the clavicle. <span class="citation" data-cites="mcminnLastAnatomyRegional2019">(<a href="references.html#ref-mcminnLastAnatomyRegional2019" role="doc-biblioref">McMinn 2019</a>)</span></p></li>
<li><p>This space is best appreciated by intimate knowledge of three things:</p>
<ul>
<li><p>The Coracoid Process and its attachments</p></li>
<li><p>The Pectoralis Minor Muscle</p></li>
<li><p>The Clavipectoral Fascia</p></li>
</ul></li>
</ul>
<p><strong>The Coracoid Process:</strong></p>
<ul>
<li><p>Arising from the Scapula as a ‘process’, this broad-based bony landmark offers attachment to muscles and ligaments.</p></li>
<li><p>The relevant attachments being the pectoralis minor muscle occupying the medial border for about 2cm behind its tip. The tip itself having a medial and lateral facet for the short head of biceps and the coracobrachialis muscles respectively.</p></li>
</ul>
<p><strong>Pectoralis Minor Muscle:</strong></p>
<p>Attached to the bone of the third, fourth and fifth ribs AND the medial border of the coracoid process.</p>
<p><strong>Clavipectoral Fascia:</strong></p>
<p>A sheet of fascial membrane that fills the space between the clavicle and pectoralis minor splitting and encompassing the subclavius muscle. Its superior portion is what can be thickened and become a tight band referred to as the costocoracoid ligament.</p>
<p><strong>Phrenic Nerve Anomaly:</strong></p>
<p>The Phrenic Nerve normally runs anterior to the Subclavian Vein. A rare anomaly is the nerve compressing the vein anteriorly and in very rare circumstances due to the timing of development can run through the vein itself.</p>
<p>Anomalous anatomy can also cause TOS especially when patients have a Cervical Rib and anomalous first ribs or a congenital band attaching to the first rib.</p>
<ul>
<li><p>Incidence of anomalous first ribs and cervical ribs is 0.76% and 0.75% respectively.</p></li>
<li><p>Incidence of bands are as high as 63% in the general population. <span class="citation" data-cites="humphries124ThoracicOutlet2019">(<a href="references.html#ref-humphries124ThoracicOutlet2019" role="doc-biblioref">Humphries and Freischlag 2019b</a>)</span></p></li>
</ul>
<p>nTOS</p>
<ul>
<li><p>Scalene Triangle compression – most common cause of brachial plexus and neurogenic TOS</p></li>
<li><p>Cervical Rib and Anomalous First Rib</p></li>
</ul>
<p>aTOS</p>
<ul>
<li><p>Cervical Rib and Anomalous First Rib</p></li>
<li><p>Scalene Triangle compression</p></li>
</ul>
<p>vTOS</p>
<ul>
<li><p>Costoclavicular Passage</p></li>
<li><p>Subcoracoid Space</p></li>
</ul>
</section>
<section id="presentation-5" class="level3" data-number="3.8.2">
<h3 data-number="3.8.2" class="anchored" data-anchor-id="presentation-5"><span class="header-section-number">3.8.2</span> Presentation</h3>
<ul>
<li><p>Identify symptoms and thoroughly interrogate timing</p></li>
<li><p>Exclude history of trauma</p></li>
<li><p>Associated symptoms like headache, visual disturbance, neurology in the upper limb</p></li>
<li><p>Exclude Carpal Tunnel and Antecubital Tunnel Syndromes if symptoms are isolated to the arm or forearm or hand</p></li>
<li><p>Patients with vTOS may present acutely and have acute or sub acute Upper Limb DVT</p></li>
<li><p>Patients with aTOS need to be investigated and assessed urgently given risk of ischemia.</p></li>
</ul>
</section>
<section id="evaluation-9" class="level3" data-number="3.8.3">
<h3 data-number="3.8.3" class="anchored" data-anchor-id="evaluation-9"><span class="header-section-number">3.8.3</span> Evaluation</h3>
<section id="clinical-examination" class="level4" data-number="3.8.3.1">
<h4 data-number="3.8.3.1" class="anchored" data-anchor-id="clinical-examination"><span class="header-section-number">3.8.3.1</span> Clinical Examination</h4>
<p>Provocative maneuvers are largely used for nTOS. While these are described and mentioned in most texts their utility largely is beyond the scope of a vascular surgeon’s assessment and diagnosis of nTOS.</p>
<p><strong>Adson Test</strong></p>
<ul>
<li><p>Extended abducted and externally rotated arm – palpate radial pulse</p></li>
<li><p>Rotate and laterally flex the neck to the ipsilateral side while inhaling deeply.</p></li>
<li><p>A positive test results in reduction or complete obliteration of radial pulse</p></li>
</ul>
<p><strong>Roos Test / EAST test</strong></p>
<ul>
<li><p>Patient seated and both arms abducted 90 degrees and externally rotated and elbows flexed at 90 degrees.</p></li>
<li><p>Open and close hands for 3 minutes or until pain or paraesthesia sets in.</p></li>
</ul>
<p><strong>Elveys Test</strong></p>
<ul>
<li><p>Abduct both arms to 90 degrees with elbows extended and dorsiflex both wrists.</p></li>
<li><p>If pain is elicited as wrists dorsiflexed then test is positive.</p></li>
<li><p>A further manoeuvre is then performed, laterally flex the head on each side, if pain is elicited on the contralateral side to which the head is flexed then test is positive. <span class="citation" data-cites="humphries124ThoracicOutlet2019">(<a href="references.html#ref-humphries124ThoracicOutlet2019" role="doc-biblioref">Humphries and Freischlag 2019b</a>)</span></p></li>
</ul>
</section>
<section id="non-invasive-imaging-or-vascular-lab-studies" class="level4" data-number="3.8.3.2">
<h4 data-number="3.8.3.2" class="anchored" data-anchor-id="non-invasive-imaging-or-vascular-lab-studies"><span class="header-section-number">3.8.3.2</span> Non-invasive imaging or vascular lab studies</h4>
<ul>
<li><p>DBI</p></li>
<li><p>Arterial Duplex</p></li>
<li><p>Venous Duplex</p></li>
<li><p>CT – CTV commonly performed in acute upper limb DVT and suspicion of vTOS</p></li>
<li><p>CTA for the evaluation of aTOS and excluding other causes of embolisation</p></li>
<li><p>MRI – for further evaluation of the anatomy and related neurovascular compression</p></li>
<li><p>Electromyography and Nerve Conduction Studies for nTOS</p></li>
</ul>
</section>
</section>
<section id="management-9" class="level3" data-number="3.8.4">
<h3 data-number="3.8.4" class="anchored" data-anchor-id="management-9"><span class="header-section-number">3.8.4</span> Management</h3>
<p>After the appropriate evaluation, if decompression of thoracic outlet is deemed appropriate, there are multiple approaches to the first rib resections.</p>
<table class="table">
<colgroup>
<col style="width: 8%">
<col style="width: 34%">
<col style="width: 56%">
</colgroup>
<thead>
<tr class="header">
<th></th>
<th>Advantages</th>
<th>Disadvantages</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Transa xillary</strong></td>
<td>Cosmetically more appealing as it has a limited hidden scar</td>
<td><p>Difficult to visualize the anatomy, dependent on good assistance</p>
<p>Risk of injury to T1 nerve root, phrenic nerve, long thoracic, brachial plexus , subclavian vein and arterial with limited exposure to repair</p>
<p>Not able to approach cervical ribs, scalene triangle or patch vein.</p></td>
</tr>
<tr class="even">
<td><ul>
<li><p>*Supracla</p>
<p>vicular**</p></li>
</ul></td>
<td><p>Good for scalene triangle access and debulking and cervical rib resection</p>
<p>Required for aTOS if arterial reconstruction necessary</p></td>
<td><p>Unable to decompress venous compression or visualize vein adequately</p>
<p>Cosmetically less appealing</p></td>
</tr>
<tr class="odd">
<td><ul>
<li><p>*Infracla</p>
<p>vicular**</p></li>
</ul></td>
<td><p>Good access for venous decompression</p>
<p>Allows for excision of subclavius muscle and costoclavicular ligament</p></td>
<td><p>Unable to expose subclavian artery or decompress brachial plexus.</p>
<p>Difficult to access most posterior aspect of rib</p>
<p>Cosmetically less appealing</p></td>
</tr>
<tr class="even">
<td><strong>Paracla vicular</strong></td>
<td>Useful if mixed etiology TOS to adequately decompression all neurovascular structures</td>
<td>Requires two incisions one above and below the clavicle</td>
</tr>
</tbody>
</table>
<p><span class="citation" data-cites="siracuseInfraclavicularFirstRib2015">Siracuse et al. (<a href="references.html#ref-siracuseInfraclavicularFirstRib2015" role="doc-biblioref">2015</a>)</span></p>
<section id="post-operative-complications" class="level4" data-number="3.8.4.1">
<h4 data-number="3.8.4.1" class="anchored" data-anchor-id="post-operative-complications"><span class="header-section-number">3.8.4.1</span> Post operative complications</h4>
<ul>
<li><p>Post operative patients with hemodynamic instability and ipsilateral effusion on xray should go back to OR for exploration and hemorrhage control. <span class="citation" data-cites="rinehardtCurrentPracticeThoracic2017">Rinehardt, Scarborough, and Bennett (<a href="references.html#ref-rinehardtCurrentPracticeThoracic2017" role="doc-biblioref">2017</a>)</span></p></li>
<li><p>Chyle leak often managed with adequate drainage and medium chain fatty acid diet. Persistent leak should undergo wound exploration and ligation of thoracic duct (most often encountered on the left) or VATS thoracic duct ligation.<span class="citation" data-cites="delaney2017">(<a href="references.html#ref-delaney2017" role="doc-biblioref">Delaney et al. 2017</a>)</span> IR embolization has also been shown to be effective.<span class="citation" data-cites="cope1999">(<a href="references.html#ref-cope1999" role="doc-biblioref">Cope, Salem, and Kaiser 1999</a>)</span></p></li>
</ul>
</section>
</section>
<section id="vtos" class="level3" data-number="3.8.5">
<h3 data-number="3.8.5" class="anchored" data-anchor-id="vtos"><span class="header-section-number">3.8.5</span> vTOS</h3>
<section id="demographics" class="level4" data-number="3.8.5.1">
<h4 data-number="3.8.5.1" class="anchored" data-anchor-id="demographics"><span class="header-section-number">3.8.5.1</span> Demographics</h4>
<ul>
<li><p>Incidence: 2/100,000 persons</p></li>
<li><p>Age: 18 years to 30 years <span class="citation" data-cites="illigComprehensiveReviewPagetSchroetter2010">(<a href="references.html#ref-illigComprehensiveReviewPagetSchroetter2010" role="doc-biblioref">Karl A. Illig and Doyle 2010</a>)</span></p></li>
<li><p>M&gt;F</p></li>
<li><p><strong>Paget Schroetter Syndrome</strong></p>
<ul>
<li><p>First defined by Hughes in 1949 in reference to Sir James Paget who in a hundred years earlier defined acute arm swelling and pain as possibly related to vasospasm and then von Schroetter who in 1884 attributed to the presentation to subclavian and axillary vein thrombosis. <span class="citation" data-cites="humphries123ThoracicOutlet2019">(<a href="references.html#ref-humphries123ThoracicOutlet2019" role="doc-biblioref">Humphries and Freischlag 2019a</a>)</span></p></li>
<li><p>Now vTOS and Paget Schroetter Syndrome are used synonymously.</p></li>
<li><p>Paget Schroetter Syndrome accounts for 10-20% of all upper extremity deep vein thrombosis. <span class="citation" data-cites="sekharYearbookVascularEndovascular2018">(<a href="references.html#ref-sekharYearbookVascularEndovascular2018" role="doc-biblioref">Sekhar 2018</a>)</span></p></li>
</ul></li>
</ul>
</section>
<section id="presentation-6" class="level4" data-number="3.8.5.2">
<h4 data-number="3.8.5.2" class="anchored" data-anchor-id="presentation-6"><span class="header-section-number">3.8.5.2</span> Presentation</h4>
<ul>
<li><p>Upper Limb edema, pain and cyanosis. Edema affects the shoulder, arm and hand and characteristically non pitting.</p></li>
<li><p>Collateral vein dilatation over the shoulder, neck and anterior chest wall to accommodate for the increased venous hypertension. <span class="citation" data-cites="humphries123ThoracicOutlet2019">(<a href="references.html#ref-humphries123ThoracicOutlet2019" role="doc-biblioref">Humphries and Freischlag 2019a</a>)</span></p></li>
<li><p>Pain on exertion of the upper limb described as stabbing, aching or tightness.</p></li>
<li><p>The reported incidence of PE following Upper Limb DVT is &lt;12%. <span class="citation" data-cites="humphries123ThoracicOutlet2019">(<a href="references.html#ref-humphries123ThoracicOutlet2019" role="doc-biblioref">Humphries and Freischlag 2019a</a>)</span></p></li>
</ul>
</section>
<section id="evaluation-10" class="level4" data-number="3.8.5.3">
<h4 data-number="3.8.5.3" class="anchored" data-anchor-id="evaluation-10"><span class="header-section-number">3.8.5.3</span> Evaluation</h4>
<ul>
<li><p>A differential diagnosis for Upper Limb DVT</p>
<ul>
<li><p>vTOS</p></li>
<li><p>Congenital Phrenic Nerve anomaly</p></li>
<li><p>History of Fracture, Clavicular Fracture and malunion</p></li>
<li><p>Repetitive arm provocative manoeuvres, check occupation and history of body-building</p>
<ul>
<li>Pectoralis Minor Hypertrophy.</li>
</ul></li>
</ul></li>
<li><p>Exclude Pulmonary Embolism</p></li>
<li><p>Exclude Venous Gangrene and Phlegmasia of the upper limb</p></li>
</ul>
</section>
<section id="management-10" class="level4" data-number="3.8.5.4">
<h4 data-number="3.8.5.4" class="anchored" data-anchor-id="management-10"><span class="header-section-number">3.8.5.4</span> Management</h4>
<p>Limited evidence due to lack of RCT’s. Majority of evidence based on retrospective studies.</p>
<ul>
<li><p>Prevent immediate risk</p></li>
<li><p>Return patient to unrestricted use of the affected extremity</p></li>
<li><p>Prevent recurrence of thrombosis without the need of long-term anticoagulation</p></li>
<li><p>Prevent long term Post Phlebitic Limb Syndrome</p></li>
</ul>
<section id="medical-management" class="level5" data-number="3.8.5.4.1">
<h5 data-number="3.8.5.4.1" class="anchored" data-anchor-id="medical-management"><span class="header-section-number">3.8.5.4.1</span> Medical Management</h5>
<ul>
<li><p>As per ACCP Guidelines: Initial management is anticoagulation regardless of etiology. <span class="citation" data-cites="kearonAntithromboticTherapyVTE2016">(<a href="references.html#ref-kearonAntithromboticTherapyVTE2016" role="doc-biblioref">Kearon et al. 2016</a>)</span></p>
<ul>
<li><p>The limitations of anticoagulation alone are that the slow recanalization of the thrombus may lead to eventual valvular damage and intravenous scarring. <span class="citation" data-cites="sekharYearbookVascularEndovascular2018">(<a href="references.html#ref-sekharYearbookVascularEndovascular2018" role="doc-biblioref">Sekhar 2018</a>)</span></p></li>
<li><p>Thrombolysis has been considered superior to anticoagulation alone in minimizing valvular damage due to residual clot. <span class="citation" data-cites="urschelSurgeryRemainsMost2008">(<a href="references.html#ref-urschelSurgeryRemainsMost2008" role="doc-biblioref">Urschel and Patel 2008</a>)</span></p></li>
<li><p>Systemic Lysis – non favored due to risk of intracranial hemorrhage. <span class="citation" data-cites="grunwaldCatheterDirectedThrombolysisTreatment2004">(<a href="references.html#ref-grunwaldCatheterDirectedThrombolysisTreatment2004" role="doc-biblioref">Grunwald and Hofmann 2004</a>)</span></p></li>
<li><p>Catheter Directed Lysis (CDT) – carries a lower risk of intracranial hemorrhage.</p></li>
<li><p>Patient should be maintained in a compression sleeve until definitive decompression can be performed.</p></li>
</ul></li>
<li><p>Optimal timing of CDT</p>
<ul>
<li>Within 14 days of onset of thrombosis. Excellent results have been reported following CDT if initiated before 14 days. <span class="citation" data-cites="wilsonFibrinolyticTherapyIdiopathic1990">(<a href="references.html#ref-wilsonFibrinolyticTherapyIdiopathic1990" role="doc-biblioref">Wilson, Zahn, and Newman 1990</a>)</span></li>
</ul></li>
</ul>
</section>
<section id="surgery" class="level5" data-number="3.8.5.4.2">
<h5 data-number="3.8.5.4.2" class="anchored" data-anchor-id="surgery"><span class="header-section-number">3.8.5.4.2</span> Surgery</h5>
<ul>
<li><p>After initial management patients are generally divided into two groups, unsuccessful or successful thrombolysis.</p></li>
<li><p>Persistent stenosis or signs of extrinsic compression, on venography, has generally been perceived as a significant risk of recurrent thrombosis.</p></li>
<li><p>Surgery for vTOS remains to be mainly Rib Resection and decompression of the subclavian vein with or without venolysis and patch plasty either surgical or endovenous.</p></li>
<li><p>Surgical treatment of severe resistant subclavian vein stenosis in the setting of vTOS is rib resection by paraclavicular approach and vein patch plasty. <span class="citation" data-cites="melbyComprehensiveSurgicalManagement2008">(<a href="references.html#ref-melbyComprehensiveSurgicalManagement2008" role="doc-biblioref">Melby et al. 2008</a>)</span></p></li>
<li><p>Venous occlusion in vTOS may be treated with jugular turn down or venous bypass to IJ of SVC if patients remain symptomatic. <span class="citation" data-cites="vemuriDiagnosisTreatmentEffortinduced2016">(<a href="references.html#ref-vemuriDiagnosisTreatmentEffortinduced2016" role="doc-biblioref">Vemuri et al. 2016</a>)</span></p></li>
</ul>
</section>
</section>
<section id="summary" class="level4" data-number="3.8.5.5">
<h4 data-number="3.8.5.5" class="anchored" data-anchor-id="summary"><span class="header-section-number">3.8.5.5</span> Summary</h4>
<section id="controversy" class="level5" data-number="3.8.5.5.1">
<h5 data-number="3.8.5.5.1" class="anchored" data-anchor-id="controversy"><span class="header-section-number">3.8.5.5.1</span> Controversy</h5>
<ul>
<li><p>There is a lack of consensus around the necessity of surgical rib resection, the timing and the requirement for vein patch plasty.</p></li>
<li><p>Options post recanalization:</p>
<ul>
<li><p>Deferring surgical decompression for 1-3 months after thrombolysis to allow for healing of the venous endothelium and resolution of the acute inflammatory process. <span class="citation" data-cites="humphries123ThoracicOutlet2019">(<a href="references.html#ref-humphries123ThoracicOutlet2019" role="doc-biblioref">Humphries and Freischlag 2019a</a>)</span></p></li>
<li><p>Decompression during the same admission, as the thrombolysis, with the main benefit being to reduce the risk of re-occlusion. <span class="citation" data-cites="humphries123ThoracicOutlet2019 molinaPagetSchroetterSyndromeTreated2007">(<a href="references.html#ref-humphries123ThoracicOutlet2019" role="doc-biblioref">Humphries and Freischlag 2019a</a>; <a href="references.html#ref-molinaPagetSchroetterSyndromeTreated2007" role="doc-biblioref">Molina, Hunter, and Dietz 2007</a>)</span></p></li>
<li><p>Post decompression venography and treatment 2 weeks post rib resection may help to prevent recurrence and long term vein patency. <span class="citation" data-cites="changRoutineVenographyFollowing2012">(<a href="references.html#ref-changRoutineVenographyFollowing2012" role="doc-biblioref">K. Z. Chang et al. 2012</a>)</span></p></li>
</ul></li>
</ul>
</section>
<section id="landmark-papers" class="level5" data-number="3.8.5.5.2">
<h5 data-number="3.8.5.5.2" class="anchored" data-anchor-id="landmark-papers"><span class="header-section-number">3.8.5.5.2</span> Landmark papers</h5>
<ol type="1">
<li><p>Lugo J et al – Acute Paget Schroetter syndrome: does the first rib routinely need to be removed after thrombolysis? Annals of Vascular Surgery 2015 <span class="citation" data-cites="lugoAcutePagetSchroetter2015">(<a href="references.html#ref-lugoAcutePagetSchroetter2015" role="doc-biblioref">Lugo et al. 2015</a>)</span></p>
<ol type="1">
<li><p>Systematic literature review analysis. Patients divided into three groups</p>
<ol type="1">
<li><p>First Rib resection (FRR) – n=448</p></li>
<li><p>First Rib resection and endovenous venoplasty (FRR and PLASTY) n=68</p></li>
<li><p>No further intervention after Thrombolysis n=168</p></li>
</ol></li>
<li><p>Symptom relief after initial follow up more likely in FRR (95%) and FRR and PLASTY (93%) compared to no rib removed (54%) – p&lt;0.0001</p></li>
<li><p>Results showed superior patency with FRR and PLASTY and FRR compared to anticoagulation alone.</p></li>
<li><p>Conclusion was that patients are more likely to experience greater long-term results with FRR compared to no FRR.</p></li>
</ol></li>
<li><p>Sajid MS et al – Upper limb vein thrombosis: a literature review to streamline the protocol for management. Acta Haematology 2007 <span class="citation" data-cites="sajidUpperLimbDeep2007">(<a href="references.html#ref-sajidUpperLimbDeep2007" role="doc-biblioref">Sajid et al. 2007</a>)</span></p>
<ul>
<li>Comprehensive review identifying the key papers on this topic and allows for a clear view of the best management strategy.</li>
</ul></li>
<li><p>Vemuri, C., Salehi, P., Benarroch-Gampel, J., McLaughlin, L. N., &amp; Thompson, R. W. (2016). Diagnosis and treatment of effort-induced thrombosis of the axillary subclavian vein due to venous thoracic outlet syndrome. <em>Journal of Vascular Surgery: Venous and Lymphatic Disorders</em>, <em>4</em>(4), 485–500. <span class="citation" data-cites="vemuriDiagnosisTreatmentEffortinduced2016">(<a href="references.html#ref-vemuriDiagnosisTreatmentEffortinduced2016" role="doc-biblioref">Vemuri et al. 2016</a>)</span></p>
<ul>
<li>Comprehensive summary of management strategy for effort induced thrombosis.</li>
</ul></li>
</ol>
</section>
</section>
</section>
<section id="atos" class="level3" data-number="3.8.6">
<h3 data-number="3.8.6" class="anchored" data-anchor-id="atos"><span class="header-section-number">3.8.6</span> aTOS</h3>
<section id="presentation-7" class="level4" data-number="3.8.6.1">
<h4 data-number="3.8.6.1" class="anchored" data-anchor-id="presentation-7"><span class="header-section-number">3.8.6.1</span> Presentation</h4>
<ul>
<li><p>Most common: Hand ischemia due to arterial compression or microembolization with subclavian artery aneurysm and pulsatile supraclavicular mass <span class="citation" data-cites="boll122ThoracicOutlet2019">(<a href="references.html#ref-boll122ThoracicOutlet2019" role="doc-biblioref">Boll and Valentine 2019</a>)</span></p></li>
<li><p>Less common: Exertional pain, unilateral Raynaud’s Phenomena, retrograde embolisation and neurological symptoms</p></li>
<li><p>Differential Diagnosis</p>
<ul>
<li><p>Trauma</p></li>
<li><p>Primary and Secondary Raynaud’s Phenomena</p></li>
<li><p>Small Vessel Vasculitis</p></li>
<li><p>Connective Tissue Disorders</p></li>
<li><p>Thromboangiitis Obliterans</p></li>
<li><p>Arterial Embolisation – Aortic or Central Source</p></li>
<li><p>Radiation Arteritis</p></li>
<li><p>Atherosclerotic / Dissection causes</p></li>
</ul></li>
<li><p>The different anatomical abnormalities causing aTOS <span class="citation" data-cites="boll122ThoracicOutlet2019">(<a href="references.html#ref-boll122ThoracicOutlet2019" role="doc-biblioref">Boll and Valentine 2019</a>)</span></p>
<ul>
<li><p>Cervical Rib (60%)</p></li>
<li><p>Anomalous First Rib (18%)</p></li>
<li><p>Fibrocartilaginous band (15%)</p></li>
<li><p>Clavicular Fracture (6%)</p></li>
<li><p>Enlarged C7 transverse process (1%)</p></li>
</ul></li>
</ul>
</section>
<section id="evaluation-11" class="level4" data-number="3.8.6.2">
<h4 data-number="3.8.6.2" class="anchored" data-anchor-id="evaluation-11"><span class="header-section-number">3.8.6.2</span> Evaluation</h4>
<p>Clinical Examination</p>
<ul>
<li><p>Audible Bruit / Palpable thrill over the supraclavicular fossa</p></li>
<li><p>Pulsatile mass</p></li>
<li><p>Distal ischemic lesions in the distal hand – Splinter hemorrhages</p></li>
<li><p>Positive Adson Test</p></li>
</ul>
<p>Most useful studies are pulse volume recordings (PVR) and duplex to identify aneurysm or sites of embolization. Stress test is not reliable for diagnosis. <span class="citation" data-cites="vemuriClinicalPresentationManagement2017 criadoSpectrumArterialCompression2010">(<a href="references.html#ref-vemuriClinicalPresentationManagement2017" role="doc-biblioref">Vemuri et al. 2017</a>; <a href="references.html#ref-criadoSpectrumArterialCompression2010" role="doc-biblioref">Criado, Berguer, and Greenfield 2010</a>)</span></p>
</section>
<section id="management-11" class="level4" data-number="3.8.6.3">
<h4 data-number="3.8.6.3" class="anchored" data-anchor-id="management-11"><span class="header-section-number">3.8.6.3</span> Management</h4>
<ul>
<li><p>Symptomatic patients are generally indicated for treatment. Unlike asymptomatic patients in whom it may be appropriate to manage conservatively. <span class="citation" data-cites="boll122ThoracicOutlet2019">(<a href="references.html#ref-boll122ThoracicOutlet2019" role="doc-biblioref">Boll and Valentine 2019</a>)</span></p>
<ul>
<li><p>Scher Staging of aTOS</p>
<ul>
<li><p>Stage 0: Asymptomatic</p></li>
<li><p>Stage 1: Stenosis of Subclavian Artery with minor post stenotic dilatation with no intimal disruption</p></li>
<li><p>Stage 2: Subclavian artery aneurysm with intimal damage and mural thrombus</p></li>
<li><p>Stage 3: Distal embolisation from subclavian artery disease</p></li>
</ul></li>
</ul></li>
<li><p>Supraclavicular rib resection is the most suitable for adequate arterial reconstruction. Transaxillary has been argued to offer more complete rib resection however arterial repair is not possible in this approach.</p></li>
<li><p>Subclavian artery repair is necessary in Scher Stages 2 and 3 and in some cases 1. Arterial repair with conduit either GSV, Femoral Vein or prosthetic have been described. Ringed PTFE offers good patency and resistance to kinking in this functional anatomical location.</p></li>
</ul>
</section>
</section>
<section id="ntos" class="level3" data-number="3.8.7">
<h3 data-number="3.8.7" class="anchored" data-anchor-id="ntos"><span class="header-section-number">3.8.7</span> nTOS</h3>
<section id="demographics-1" class="level4" data-number="3.8.7.1">
<h4 data-number="3.8.7.1" class="anchored" data-anchor-id="demographics-1"><span class="header-section-number">3.8.7.1</span> Demographics</h4>
<p>Neurogenic TOS is largely a clinical diagnosis with symptoms and signs pertaining to nerve compression most commonly the lower trunk of the brachial plexus.</p>
<ul>
<li><p>F&gt;M – 70% Female</p></li>
<li><p>Ages 20-40</p></li>
<li><p>Occupational Exposure</p></li>
<li><p>Trauma history - often associated with recent history of neck trauma.</p></li>
</ul>
</section>
<section id="presentation-8" class="level4" data-number="3.8.7.2">
<h4 data-number="3.8.7.2" class="anchored" data-anchor-id="presentation-8"><span class="header-section-number">3.8.7.2</span> Presentation</h4>
<ul>
<li><p>Symptoms <span class="citation" data-cites="sadeghi-azandaryaniThoracicOutletSyndrome2009 sandersDiagnosisThoracicOutlet2007">(<a href="references.html#ref-sadeghi-azandaryaniThoracicOutletSyndrome2009" role="doc-biblioref">Sadeghi-Azandaryani et al. 2009</a>; <a href="references.html#ref-sandersDiagnosisThoracicOutlet2007" role="doc-biblioref">Sanders, Hammond, and Rao 2007</a>)</span></p>
<ul>
<li><p>Paraesthesia (98%)</p></li>
<li><p>Trapezius pain (92%)</p></li>
<li><p>Neck, shoulder or arm pain (88%) - usually involves nerve roots so isolated hand symptoms is rare.</p></li>
<li><p>Supraclavicular pain with or without occipital headache (76%)</p></li>
<li><p>Chest pain (72%)</p></li>
<li><p>Weakness</p></li>
<li><p>Swelling</p></li>
</ul></li>
<li><p>Positional Effects</p>
<ul>
<li><p>Reproducible exacerbation of symptoms</p></li>
<li><p>Lying supine with arms overhead</p></li>
<li><p>Overhead activities -occupational or recreational</p></li>
</ul></li>
<li><p>Weakness and Muscle Atrophy</p>
<ul>
<li><p>Hypothenar atrophy</p></li>
<li><p>Drop-off in athletic performance</p></li>
<li><p>Inability to carry out activities of daily living</p></li>
</ul></li>
</ul>
</section>
<section id="management-12" class="level4" data-number="3.8.7.3">
<h4 data-number="3.8.7.3" class="anchored" data-anchor-id="management-12"><span class="header-section-number">3.8.7.3</span> Management</h4>
<p>As the patient has already seen multiple specialists and physiotherapists, the role of the vascular surgeon with nTOS is often limited but should focus on:</p>
<ul>
<li><p>Exclude other causes</p></li>
<li><p>Confirm diagnosis – Neurophysiologic Tests (EMG and NCS)</p></li>
<li><p>Seek alternate opinion</p></li>
<li><p>Trial of Physiotherapy and non-operative management - patients should be evaluated and undergo a 6 week course of physical therapy. This physical therapy focuses on scalene and pectoralis stretching improving mobility of the shoulder and strengthening the arm. Many improve with physical therapy. <span class="citation" data-cites="baldermanPhysicalTherapyManagement2019">(<a href="references.html#ref-baldermanPhysicalTherapyManagement2019" role="doc-biblioref">Balderman et al. 2019</a>)</span></p></li>
<li><p>Anterior scalene lidocaine block may provide temporary symptom relief (~7 days) and may help identify those patients most likely to benefit from surgical decompression. <span class="citation" data-cites="salhanPC214UltrasoundGuidedAnesthetic2016 lumImpactAnteriorScalene2012">(<a href="references.html#ref-salhanPC214UltrasoundGuidedAnesthetic2016" role="doc-biblioref">Salhan et al. 2016</a>; <a href="references.html#ref-lumImpactAnteriorScalene2012" role="doc-biblioref">Lum et al. 2012</a>)</span></p></li>
<li><p>Botulinum injection may give an average of 6 weeks of relief. <span class="citation" data-cites="salhanPC214UltrasoundGuidedAnesthetic2016">(<a href="references.html#ref-salhanPC214UltrasoundGuidedAnesthetic2016" role="doc-biblioref">Salhan et al. 2016</a>)</span></p></li>
<li><p>Be selective in patients who may require surgery</p></li>
</ul>
<p>Surgery with Rib resection often is accomplished with transaxillary or supraclavicular approach, particularly if scalenectomy or cervical rib resection is necessary.</p>
</section>
</section>
</section>
<section id="upper-extremity-lymphedema" class="level2" data-number="3.9">
<h2 data-number="3.9" class="anchored" data-anchor-id="upper-extremity-lymphedema"><span class="header-section-number">3.9</span> Upper Extremity Lymphedema</h2>
<section id="etiology-8" class="level3" data-number="3.9.1">
<h3 data-number="3.9.1" class="anchored" data-anchor-id="etiology-8"><span class="header-section-number">3.9.1</span> Etiology</h3>
<p>Often due to breast cancer therapy and axillary lymph node dissection.<span class="citation" data-cites="morrell2005">(<a href="references.html#ref-morrell2005" role="doc-biblioref">Morrell et al. 2005</a>)</span></p>
</section>
<section id="management-13" class="level3" data-number="3.9.2">
<h3 data-number="3.9.2" class="anchored" data-anchor-id="management-13"><span class="header-section-number">3.9.2</span> Management</h3>
<p>Initial treatment includes decongestive therapy, such as daily massage for 2-4 weeks. Once the girth and symptoms stabilize, then can transition to long term management with compression sleeve.<span class="citation" data-cites="mondry2004">(<a href="references.html#ref-mondry2004" role="doc-biblioref">Mondry, Riffenburgh, and Johnstone 2004</a>)</span></p>
<p>Severe cases my require lymph node transfer.<span class="citation" data-cites="warren2007">(<a href="references.html#ref-warren2007" role="doc-biblioref">Warren et al. 2007</a>)</span></p>
<p>Lymphangiosarcoma in the setting of lymphedema (Stewart-Treves syndrome) without distant disease is best managed with wide local excision and adjuvant chemoradiation. Prognosis is poor.<span class="citation" data-cites="sharma2012">(<a href="references.html#ref-sharma2012" role="doc-biblioref">Sharma and Schwartz 2012</a>)</span></p>


<div id="refs" class="references csl-bib-body hanging-indent" role="doc-bibliography" style="display: none">
<div id="ref-aburahma2000" class="csl-entry" role="doc-biblioentry">
AbuRahma, Ali F., Patrick A. Robinson, and Tucker G. Jennings. 2000. <span>“Carotid-Subclavian Bypass Grafting with Polytetrafluoroethylene Grafts for Symptomatic Subclavian Artery Stenosis or Occlusion: A 20-Year Experience.”</span> <em>Journal of Vascular Surgery</em> 32 (3): 411–19. <a href="https://doi.org/10.1067/mva.2000.108644">https://doi.org/10.1067/mva.2000.108644</a>.
</div>
<div id="ref-aiello2011" class="csl-entry" role="doc-biblioentry">
Aiello, Francesco, and Nicholas J. Morrissey. 2011. <span>“Open and Endovascular Management of Subclavian and Innominate Arterial Pathology.”</span> <em>Seminars in Vascular Surgery</em> 24 (1): 31–35. <a href="https://doi.org/10.1053/j.semvascsurg.2011.04.001">https://doi.org/10.1053/j.semvascsurg.2011.04.001</a>.
</div>
<div id="ref-bagir2017" class="csl-entry" role="doc-biblioentry">
Bagir, Melih, Emrah Sayit, and Asli Tanrivermis Sayit. 2017. <span>“Pseudoaneurysm of the Radial Artery on the Hand Secondary to Stabbing.”</span> <em>Annals of Vascular Surgery</em> 41 (May): 280.e7–10. <a href="https://doi.org/10.1016/j.avsg.2016.09.027">https://doi.org/10.1016/j.avsg.2016.09.027</a>.
</div>
<div id="ref-baig84UpperExtremity2019" class="csl-entry" role="doc-biblioentry">
Baig, m shadman, and Carlos H. Timaran. 2019. <span>“84. <span>Upper</span> Extremity Aneurysms.”</span> In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em>. <span>Elsevier Inc.</span>
</div>
<div id="ref-baldermanPhysicalTherapyManagement2019" class="csl-entry" role="doc-biblioentry">
Balderman, Joshua, Ahmmad A. Abuirqeba, Lindsay Eichaker, Cassandra Pate, Jeanne A. Earley, Michael M. Bottros, Senthil N. Jayarajan, and Robert W. Thompson. 2019. <span>“Physical Therapy Management, Surgical Treatment, and Patient-Reported Outcomes Measures in a Prospective Observational Cohort of Patients with Neurogenic Thoracic Outlet Syndrome.”</span> <em>Journal of Vascular Surgery</em> 70 (3): 832–41. <a href="https://doi.org/10.1016/j.jvs.2018.12.027">https://doi.org/10.1016/j.jvs.2018.12.027</a>.
</div>
<div id="ref-berguer1998" class="csl-entry" role="doc-biblioentry">
Berguer, R., M. D. Morasch, and R. A. Kline. 1998. <span>“Transthoracic Repair of Innominate and Common Carotid Artery Disease: Immediate and Long-Term Outcome for 100 Consecutive Surgical Reconstructions.”</span> <em>Journal of Vascular Surgery</em> 27 (1): 34–41; discussion 42. <a href="https://doi.org/10.1016/s0741-5214(98)70289-7">https://doi.org/10.1016/s0741-5214(98)70289-7</a>.
</div>
<div id="ref-berguer1999" class="csl-entry" role="doc-biblioentry">
Berguer, R., M. D. Morasch, R. A. Kline, A. Kazmers, and M. S. Friedland. 1999. <span>“Cervical Reconstruction of the Supra-Aortic Trunks: A 16-Year Experience.”</span> <em>Journal of Vascular Surgery</em> 29 (2): 239-246; discussion 246-248. <a href="https://doi.org/10.1016/s0741-5214(99)70377-0">https://doi.org/10.1016/s0741-5214(99)70377-0</a>.
</div>
<div id="ref-boll122ThoracicOutlet2019" class="csl-entry" role="doc-biblioentry">
Boll, Julia M, and R. James Valentine. 2019. <span>“122: <span>Thoracic</span> Outlet Syndrome: <span>Arterial</span>.”</span> In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em>, Ninth. Vol. 2. <span>Elsevier Health Sciences</span>.
</div>
<div id="ref-bongartz2006" class="csl-entry" role="doc-biblioentry">
Bongartz, Tim, and Eric L. Matteson. 2006. <span>“Large-Vessel Involvement in Giant Cell Arteritis.”</span> <em>Current Opinion in Rheumatology</em> 18 (1): 10–17. <a href="https://doi.org/10.1097/01.bor.0000197996.04709.4e">https://doi.org/10.1097/01.bor.0000197996.04709.4e</a>.
</div>
<div id="ref-bradaricEndovascularTherapyStenoOcclusive2015" class="csl-entry" role="doc-biblioentry">
Bradaric, Christian, Kristin Kuhs, Philip Groha, Michael Dommasch, Nicolas Langwieser, Bernhard Haller, Ilka Ott, et al. 2015. <span>“Endovascular <span>Therapy</span> for <span>Steno-Occlusive Subclavian</span> and <span>Innominate Artery Disease</span>: <span>Safety</span> and <span>Efficacy</span> at a <span>Single Center With</span> &amp;Gt;20 <span>Years</span>’ <span>Experience</span> .”</span> <em>Circulation Journal</em> 79 (3): 537–43. <a href="https://doi.org/10.1253/circj.CJ-14-0855">https://doi.org/10.1253/circj.CJ-14-0855</a>.
</div>
<div id="ref-busch2011" class="csl-entry" role="doc-biblioentry">
Busch, Kathryn. 2011. <span>“Buerger’s Disease (Thromboangiitis Obliterans): Clinical Features and Assessment by Colour Duplex Ultrasound.”</span> <em>Australasian Journal of Ultrasound in Medicine</em> 14 (4): 18–22. <a href="https://doi.org/10.1002/j.2205-0140.2011.tb00126.x">https://doi.org/10.1002/j.2205-0140.2011.tb00126.x</a>.
</div>
<div id="ref-byrne2007" class="csl-entry" role="doc-biblioentry">
Byrne, J., R. C. Darling, S. P. Roddy, M. Mehta, P. S. K. Paty, P. B. Kreienberg, B. B. Chang, K. J. Ozsvath, Y. Sternbach, and D. M. Shah. 2007. <span>“Long Term Outcome for Extra-Anatomic Arch Reconstruction. An Analysis of 143 Procedures.”</span> <em>European Journal of Vascular and Endovascular Surgery</em> 34 (4): 444–50. <a href="https://doi.org/10.1016/j.ejvs.2007.05.016">https://doi.org/10.1016/j.ejvs.2007.05.016</a>.
</div>
<div id="ref-carr2019" class="csl-entry" role="doc-biblioentry">
Carr, Marcus P., Giles W. Becker, Mihra S. Taljanovic, and Wendy E. McCurdy. 2019. <span>“Hypothenar Hammer Syndrome: Case Report and Literature Review.”</span> <em>Radiology Case Reports</em> 14 (7): 868–71. <a href="https://doi.org/10.1016/j.radcr.2019.04.015">https://doi.org/10.1016/j.radcr.2019.04.015</a>.
</div>
<div id="ref-chang2003" class="csl-entry" role="doc-biblioentry">
Chang, Benjamin B., Sean P. Roddy, R. Clement Darling, Dale Maharaj, Philip S. K. Paty, Paul B. Kreienberg, Kathleen J. Ozsvath, Manish Mehta, and Dhiraj M. Shah. 2003. <span>“Upper Extremity Bypass Grafting for Limb Salvage in End-Stage Renal Failure.”</span> <em>Journal of Vascular Surgery</em> 38 (6): 1313–15. <a href="https://doi.org/10.1016/s0741-5214(03)00773-0">https://doi.org/10.1016/s0741-5214(03)00773-0</a>.
</div>
<div id="ref-changRoutineVenographyFollowing2012" class="csl-entry" role="doc-biblioentry">
Chang, Kevin Z., Kendall Likes, Jasmine Demos, James H. Black, and Julie A. Freischlag. 2012. <span>“Routine <span>Venography Following Transaxillary First Rib Resection</span> and <span>Scalenectomy</span> (<span>FRRS</span>) for <span>Chronic Subclavian Vein Thrombosis Ensures Excellent Outcomes</span> and <span>Vein Patency</span>.”</span> <em>Vascular and Endovascular Surgery</em> 46 (1): 15–20. <a href="https://doi.org/10.1177/1538574411423982">https://doi.org/10.1177/1538574411423982</a>.
</div>
<div id="ref-chatterjeeAngioplastyAloneAngioplasty2013" class="csl-entry" role="doc-biblioentry">
Chatterjee, Saurav, Nishant Nerella, Saneka Chakravarty, and Jacob Shani. 2013. <span>“Angioplasty <span>Alone Versus Angioplasty</span> and <span>Stenting</span> for <span>Subclavian Artery Stenosis</span> and <span class="nocase">Meta-analysis</span>.”</span> <em>American Journal of Therapeutics</em> 20 (5): 520–23. <a href="https://doi.org/10.1097/MJT.0b013e31822831d8">https://doi.org/10.1097/MJT.0b013e31822831d8</a>.
</div>
<div id="ref-cheun2019" class="csl-entry" role="doc-biblioentry">
Cheun, Tracy J., Lalithapriya Jayakumar, Maureen K. Sheehan, Matthew J. Sideman, Lori L. Pounds, and Mark G. Davies. 2019. <span>“Outcomes of Upper Extremity Interventions for Chronic Critical Ischemia.”</span> <em>Journal of Vascular Surgery</em> 69 (1): 120–128.e2. <a href="https://doi.org/10.1016/j.jvs.2018.04.056">https://doi.org/10.1016/j.jvs.2018.04.056</a>.
</div>
<div id="ref-cinà2002" class="csl-entry" role="doc-biblioentry">
Cinà, Claudio S., Hussein A. Safar, Antonello Laganà, Goffredo Arena, and Catherine M. Clase. 2002. <span>“Subclavian Carotid Transposition and Bypass Grafting: Consecutive Cohort Study and Systematic Review.”</span> <em>Journal of Vascular Surgery</em> 35 (3): 422–29. <a href="https://doi.org/10.1067/mva.2002.120035">https://doi.org/10.1067/mva.2002.120035</a>.
</div>
<div id="ref-cohen2014" class="csl-entry" role="doc-biblioentry">
Cohen, José E., J. Moshe Gomori, Haim Anner, and Eyal Itshayek. 2014. <span>“Inadvertent Subclavian Artery Cannulation Treated by Percutaneous Closure.”</span> <em>Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia</em> 21 (11): 1973–75. <a href="https://doi.org/10.1016/j.jocn.2014.04.009">https://doi.org/10.1016/j.jocn.2014.04.009</a>.
</div>
<div id="ref-cope1999" class="csl-entry" role="doc-biblioentry">
Cope, C., R. Salem, and L. R. Kaiser. 1999. <span>“Management of Chylothorax by Percutaneous Catheterization and Embolization of the Thoracic Duct: Prospective Trial.”</span> <em>Journal of Vascular and Interventional Radiology: JVIR</em> 10 (9): 1248–54. <a href="https://doi.org/10.1016/s1051-0443(99)70227-7">https://doi.org/10.1016/s1051-0443(99)70227-7</a>.
</div>
<div id="ref-criadoSpectrumArterialCompression2010" class="csl-entry" role="doc-biblioentry">
Criado, Enrique, Ramon Berguer, and Lazar Greenfield. 2010. <span>“The Spectrum of Arterial Compression at the Thoracic Outlet.”</span> <em>Journal of Vascular Surgery</em> 52 (2): 406–11. <a href="https://doi.org/10.1016/j.jvs.2010.03.009">https://doi.org/10.1016/j.jvs.2010.03.009</a>.
</div>
<div id="ref-cuaReviewCoronarySubclavian2017" class="csl-entry" role="doc-biblioentry">
Cua, Bennett, Natasha Mamdani, David Halpin, Sunny Jhamnani, Sasanka Jayasuriya, and Carlos Mena-Hurtado. 2017. <span>“Review of Coronary Subclavian Steal Syndrome.”</span> <em>Journal of Cardiology</em> 70 (5): 432–37. <a href="https://doi.org/10.1016/j.jjcc.2017.02.012">https://doi.org/10.1016/j.jjcc.2017.02.012</a>.
</div>
<div id="ref-daniel2014" class="csl-entry" role="doc-biblioentry">
Daniel, Vijaya T., Arin L. Madenci, Louis L. Nguyen, Mohammad H. Eslami, Jeffrey A. Kalish, Alik Farber, and James T. McPhee. 2014. <span>“Contemporary Comparison of Supra-Aortic Trunk Surgical Reconstructions for Occlusive Disease.”</span> <em>Journal of Vascular Surgery</em> 59 (6): 1577–1582.e2. <a href="https://doi.org/10.1016/j.jvs.2013.12.017">https://doi.org/10.1016/j.jvs.2013.12.017</a>.
</div>
<div id="ref-delaney2017" class="csl-entry" role="doc-biblioentry">
Delaney, Sean W., Haoran Shi, Alireza Shokrani, and Uttam K. Sinha. 2017. <span>“Management of Chyle Leak After Head and Neck Surgery: Review of Current Treatment Strategies.”</span> <em>International Journal of Otolaryngology</em> 2017: 8362874. <a href="https://doi.org/10.1155/2017/8362874">https://doi.org/10.1155/2017/8362874</a>.
</div>
<div id="ref-dineen2007" class="csl-entry" role="doc-biblioentry">
Dineen, Sean, Stephen Smith, and Frank R. Arko. 2007. <span>“Successful Percutaneous Angioplasty and Stenting of the Radial Artery in a Patient with Chronic Upper Extremity Ischemia and Digital Gangrene.”</span> <em>Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists</em> 14 (3): 426–28. <a href="https://doi.org/10.1583/06-2017.1">https://doi.org/10.1583/06-2017.1</a>.
</div>
<div id="ref-dumfarth2015" class="csl-entry" role="doc-biblioentry">
Dumfarth, Julia, Alan S. Chou, Bulat A. Ziganshin, Rohan Bhandari, Sven Peterss, Maryann Tranquilli, Hamid Mojibian, Hai Fang, John A. Rizzo, and John A. Elefteriades. 2015. <span>“Atypical Aortic Arch Branching Variants: A Novel Marker for Thoracic Aortic Disease.”</span> <em>The Journal of Thoracic and Cardiovascular Surgery</em> 149 (6): 1586–92. <a href="https://doi.org/10.1016/j.jtcvs.2015.02.019">https://doi.org/10.1016/j.jtcvs.2015.02.019</a>.
</div>
<div id="ref-ehlert2019" class="csl-entry" role="doc-biblioentry">
Ehlert, Bryan A, and Christopher J. Abularrage. 2019. <span>“139. Takayasu Disease.”</span> In <em>Rutherford’s Vascular Surgery and Endovascular Therapy</em>, 9th ed., 17. Elsevier Inc.
</div>
<div id="ref-eskandari185ConditionsArising2020" class="csl-entry" role="doc-biblioentry">
Eskandari, Mark K, and Courtney E Morgan. 2020. <em>185: <span>Conditions Arising From Repetitive Trauma</span> and <span>Occupational Vascular Problems</span></em>. <em>Rutherford’s Vascular Surgery and Endovascular Therapy, 2-Volume Set</em>. <span>Elsevier Inc.</span> <a href="https://doi.org/10.1016/B978-0-323-42791-3.00185-7">https://doi.org/10.1016/B978-0-323-42791-3.00185-7</a>.
</div>
<div id="ref-ferris2000" class="csl-entry" role="doc-biblioentry">
Ferris, B. L., L. M. Taylor, K. Oyama, R. B. McLafferty, J. M. Edwards, G. L. Moneta, and J. M. Porter. 2000. <span>“Hypothenar Hammer Syndrome: Proposed Etiology.”</span> <em>Journal of Vascular Surgery</em> 31 (1 Pt 1): 104–13. <a href="https://doi.org/10.1016/s0741-5214(00)70072-3">https://doi.org/10.1016/s0741-5214(00)70072-3</a>.
</div>
<div id="ref-fujii2011" class="csl-entry" role="doc-biblioentry">
Fujii, Yuichi, Junko Soga, Takayuki Hidaka, Takaki Hata, Naomi Idei, Noritaka Fujimura, Shinsuke Mikami, et al. 2011. <span>“Color Doppler Flows of Corkscrew Collaterals in Thromboangiitis Obliterans (Buerger’s Disease) Using Color Duplex Ultrasonography.”</span> <em>Journal of the American College of Cardiology</em> 57 (25): 2539. <a href="https://doi.org/10.1016/j.jacc.2010.07.071">https://doi.org/10.1016/j.jacc.2010.07.071</a>.
</div>
<div id="ref-garygwindAnatomicExposuresVascular2013" class="csl-entry" role="doc-biblioentry">
Gary G Wind, and R. James Valentine. 2013. <em>Anatomic <span>Exposures</span> in <span>Vascular Surgery</span></em>. Second. <span>Lippincott Williams &amp; Wilkins</span>.
</div>
<div id="ref-gelberman1981" class="csl-entry" role="doc-biblioentry">
Gelberman, R. H., S. R. Garfin, P. T. Hergenroeder, S. J. Mubarak, and J. Menon. 1981. <span>“Compartment Syndromes of the Forearm: Diagnosis and Treatment.”</span> <em>Clinical Orthopaedics and Related Research</em>, no. 161 (December): 252–61.
</div>
<div id="ref-goldstein2010" class="csl-entry" role="doc-biblioentry">
Goldstein, Lee J., Joseph D. Ayers, Scott Hollenbeck, Jason A. Spector, and Ageliki G. Vouyouka. 2010. <span>“Successful Revascularization for Delayed Presentation of Radiation-Induced Distal Upper Extremity Ischemia.”</span> <em>Annals of Vascular Surgery</em> 24 (2): 257.e5–8. <a href="https://doi.org/10.1016/j.avsg.2009.07.024">https://doi.org/10.1016/j.avsg.2009.07.024</a>.
</div>
<div id="ref-grunwaldCatheterDirectedThrombolysisTreatment2004" class="csl-entry" role="doc-biblioentry">
Grunwald, Michael R., and Lawrence V. Hofmann. 2004. <span>“Catheter-<span>Directed Thrombolysis</span> for the <span>Treatment</span> of <span>Symptomatic Deep Vein Thrombosis</span>.”</span> <em>Circulation</em> 109 (2). <a href="https://doi.org/10.1161/01.CIR.0000111132.23469.70">https://doi.org/10.1161/01.CIR.0000111132.23469.70</a>.
</div>
<div id="ref-henke2009" class="csl-entry" role="doc-biblioentry">
Henke, Peter K. 2009. <span>“Contemporary Management of Acute Limb Ischemia: Factors Associated with Amputation and in-Hospital Mortality.”</span> <em>Seminars in Vascular Surgery</em> 22 (1): 34–40. <a href="https://doi.org/10.1053/j.semvascsurg.2009.01.002">https://doi.org/10.1053/j.semvascsurg.2009.01.002</a>.
</div>
<div id="ref-humphries123ThoracicOutlet2019" class="csl-entry" role="doc-biblioentry">
Humphries, Misty D, and Julie A Freischlag. 2019a. <span>“123: <span>Thoracic</span> Outlet Syndrome: <span>Venous</span>.”</span> In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em>, 2:1648–1655.e2. <span>Elsevier Inc.</span> <a href="https://doi.org/10.1016/j.mpsur.2018.12.010">https://doi.org/10.1016/j.mpsur.2018.12.010</a>.
</div>
<div id="ref-humphries124ThoracicOutlet2019" class="csl-entry" role="doc-biblioentry">
———. 2019b. <span>“124: <span>Thoracic Outlet Syndrome</span> : <span>Surgical Decompression</span> of the <span>Thoracic Outlet</span>.”</span> In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em>, Ninth. Vol. 2. <span>Elsevier Inc.</span> <a href="https://doi.org/10.1016/B978-0-323-42791-3.00124-9">https://doi.org/10.1016/B978-0-323-42791-3.00124-9</a>.
</div>
<div id="ref-illig57UpperExtremity2019" class="csl-entry" role="doc-biblioentry">
Illig, Karl A. 2019. <span>“57. <span>Upper Extremity Vascular Exposure</span>.”</span> In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em>, 12. <span>Elsevier Inc.</span>
</div>
<div id="ref-illigComprehensiveReviewPagetSchroetter2010" class="csl-entry" role="doc-biblioentry">
Illig, Karl A., and Adam J. Doyle. 2010. <span>“A Comprehensive Review of <span>Paget-Schroetter</span> Syndrome.”</span> <em>Journal of Vascular Surgery</em> 51 (6): 1538–47. <a href="https://doi.org/10.1016/j.jvs.2009.12.022">https://doi.org/10.1016/j.jvs.2009.12.022</a>.
</div>
<div id="ref-illuminati2018" class="csl-entry" role="doc-biblioentry">
Illuminati, Giulio, Giulia Pizzardi, Francesco G. Calio, Federica Masci, Rocco Pasqua, Francesca Frezzotti, and Simone Peschillo. 2018. <span>“Results of Subclavian to Carotid Artery Bypass for Occlusive Disease of the Common Carotid Artery: A Retrospective Cohort Study.”</span> <em>International Journal of Surgery (London, England)</em> 53 (May): 111–16. <a href="https://doi.org/10.1016/j.ijsu.2018.03.038">https://doi.org/10.1016/j.ijsu.2018.03.038</a>.
</div>
<div id="ref-jacklcronenwettVascularDecisionMaking2020" class="csl-entry" role="doc-biblioentry">
Jack L Cronenwett, Alik Farber, and Erica L. Mitchell. 2020. <em>Vascular <span>Decision Making</span>: <span>Medical</span>, <span>Endovascular</span>, <span>Surgical</span></em>. <span>Wolters Kluwer</span>.
</div>
<div id="ref-janssen2008" class="csl-entry" role="doc-biblioentry">
Janssen, Stan P., Emile H. Comans, Alexandre E. Voskuyl, Willem Wisselink, and Yvo M. Smulders. 2008. <span>“Giant Cell Arteritis: Heterogeneity in Clinical Presentation and Imaging Results.”</span> <em>Journal of Vascular Surgery</em> 48 (4): 1025–31. <a href="https://doi.org/10.1016/j.jvs.2008.04.054">https://doi.org/10.1016/j.jvs.2008.04.054</a>.
</div>
<div id="ref-kauvar184VascularTrauma2020" class="csl-entry" role="doc-biblioentry">
Kauvar, David S, and Larry W Kraiss. 2020. <em>184: <span>Vascular Trauma</span>: <span>Extremity</span></em>. <em>Rutherford’s Vascular Surgery and Endovascular Therapy, 2-Volume Set</em>. <span>Elsevier Inc.</span> <a href="https://doi.org/10.1016/B978-0-323-42791-3.00184-5">https://doi.org/10.1016/B978-0-323-42791-3.00184-5</a>.
</div>
<div id="ref-kearonAntithromboticTherapyVTE2016" class="csl-entry" role="doc-biblioentry">
Kearon, Clive, Elie A. Akl, Joseph Ornelas, Allen Blaivas, David Jimenez, Henri Bounameaux, Menno Huisman, et al. 2016. <span>“Antithrombotic <span>Therapy</span> for <span>VTE Disease</span>.”</span> <em>Chest</em> 149 (2): 315–52. <a href="https://doi.org/10.1016/j.chest.2015.11.026">https://doi.org/10.1016/j.chest.2015.11.026</a>.
</div>
<div id="ref-kistler2018" class="csl-entry" role="doc-biblioentry">
Kistler, Justin M., Asif M. Ilyas, and Joseph J. Thoder. 2018. <span>“Forearm Compartment Syndrome: Evaluation and Management.”</span> <em>Hand Clinics</em> 34 (1): 53–60. <a href="https://doi.org/10.1016/j.hcl.2017.09.006">https://doi.org/10.1016/j.hcl.2017.09.006</a>.
</div>
<div id="ref-landry141RaynaudPhenomenon2019" class="csl-entry" role="doc-biblioentry">
Landry, Gregory J. 2019. <span>“141. <span>Raynaud Phenomenon</span>.”</span> In <em>Rutherford <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em>. <span>Elsevier Inc.</span>
</div>
<div id="ref-landry2013" class="csl-entry" role="doc-biblioentry">
Landry, Gregory J. 2013. <span>“Current Medical and Surgical Management of Raynaud’s Syndrome.”</span> <em>Journal of Vascular Surgery</em> 57 (6): 1710–16. <a href="https://doi.org/10.1016/j.jvs.2013.03.012">https://doi.org/10.1016/j.jvs.2013.03.012</a>.
</div>
<div id="ref-landry2018" class="csl-entry" role="doc-biblioentry">
Landry, Gregory J., Courtney J. Mostul, Daniel S. Ahn, Bryant J. McLafferty, Timothy K. Liem, Erica L. Mitchell, Enjae Jung, et al. 2018. <span>“Causes and Outcomes of Finger Ischemia in Hospitalized Patients in the Intensive Care Unit.”</span> <em>Journal of Vascular Surgery</em> 68 (5): 1499–1504. <a href="https://doi.org/10.1016/j.jvs.2018.01.050">https://doi.org/10.1016/j.jvs.2018.01.050</a>.
</div>
<div id="ref-layton2006" class="csl-entry" role="doc-biblioentry">
Layton, K. F., D. F. Kallmes, H. J. Cloft, E. P. Lindell, and V. S. Cox. 2006. <span>“Bovine Aortic Arch Variant in Humans: Clarification of a Common Misnomer.”</span> <em>AJNR: American Journal of Neuroradiology</em> 27 (7): 1541–42. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977516/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977516/</a>.
</div>
<div id="ref-lejoncour2018" class="csl-entry" role="doc-biblioentry">
Le Joncour, Alexandre, Simon Soudet, Axelle Dupont, Olivier Espitia, Fabien Koskas, Philippe Cluzel, Pierre Yves Hatron, et al. 2018. <span>“Long‐term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger’s Disease): A Multicenter Study of 224 Patients.”</span> <em>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</em> 7 (23): e010677. <a href="https://doi.org/10.1161/JAHA.118.010677">https://doi.org/10.1161/JAHA.118.010677</a>.
</div>
<div id="ref-leversedge2011" class="csl-entry" role="doc-biblioentry">
Leversedge, Fraser J., Thomas J. Moore, Bret C. Peterson, and John G. Seiler. 2011. <span>“Compartment Syndrome of the Upper Extremity.”</span> <em>The Journal of Hand Surgery</em> 36 (3): 544–559; quiz 560. <a href="https://doi.org/10.1016/j.jhsa.2010.12.008">https://doi.org/10.1016/j.jhsa.2010.12.008</a>.
</div>
<div id="ref-lugoAcutePagetSchroetter2015" class="csl-entry" role="doc-biblioentry">
Lugo, Joanelle, Adam Tanious, Paul Armstrong, Martin Back, Brad Johnson, Murray Shames, Neil Moudgill, Peter Nelson, and Karl A. Illig. 2015. <span>“Acute <span>Paget</span>: <span>Does</span> the <span>First Rib Routinely Need</span> to <span>Be Removed</span> After <span>Thrombolysis</span>?”</span> <em>Annals of Vascular Surgery</em> 29 (6): 1073–77. <a href="https://doi.org/10.1016/j.avsg.2015.02.006">https://doi.org/10.1016/j.avsg.2015.02.006</a>.
</div>
<div id="ref-lumImpactAnteriorScalene2012" class="csl-entry" role="doc-biblioentry">
Lum, Ying Wei, Benjamin S. Brooke, Kendall Likes, Monica Modi, Holly Grunebach, Paul J. Christo, and Julie A. Freischlag. 2012. <span>“Impact of Anterior Scalene Lidocaine Blocks on Predicting Surgical Success in Older Patients with Neurogenic Thoracic Outlet Syndrome.”</span> <em>Journal of Vascular Surgery</em> 55 (5): 1370–75. <a href="https://doi.org/10.1016/j.jvs.2011.11.132">https://doi.org/10.1016/j.jvs.2011.11.132</a>.
</div>
<div id="ref-mansukhani2018" class="csl-entry" role="doc-biblioentry">
Mansukhani, Neel A., Kyle R. Miller, George E. Havelka, Hyde M. Russell, and Mark K. Eskandari. 2018. <span>“Aorta-Innominate Bypass Through Ministernotomy.”</span> <em>Journal of Vascular Surgery</em> 68 (2): 607–10. <a href="https://doi.org/10.1016/j.jvs.2018.01.069">https://doi.org/10.1016/j.jvs.2018.01.069</a>.
</div>
<div id="ref-masden2012" class="csl-entry" role="doc-biblioentry">
Masden, Derek L., Mitchel Seruya, and James P. Higgins. 2012. <span>“A Systematic Review of the Outcomes of Distal Upper Extremity Bypass Surgery with Arterial and Venous Conduits.”</span> <em>The Journal of Hand Surgery</em> 37 (11): 2362–67. <a href="https://doi.org/10.1016/j.jhsa.2012.07.028">https://doi.org/10.1016/j.jhsa.2012.07.028</a>.
</div>
<div id="ref-maskanakis2018" class="csl-entry" role="doc-biblioentry">
Maskanakis, Anastasios, Nikolaos Patelis, Demetrios Moris, Diamantis I. Tsilimigras, Dimitrios Schizas, Maria Diakomi, Chris Bakoyiannis, Sotirios Georgopoulos, Chris Klonaris, and Theodoros Liakakos. 2018. <span>“Stenting of Subclavian Artery True and False Aneurysms: A Systematic Review.”</span> <em>Annals of Vascular Surgery</em> 47 (February): 291–304. <a href="https://doi.org/10.1016/j.avsg.2017.08.013">https://doi.org/10.1016/j.avsg.2017.08.013</a>.
</div>
<div id="ref-mcminnLastAnatomyRegional2019" class="csl-entry" role="doc-biblioentry">
McMinn, Robert H. 2019. <em>Last’s <span>Anatomy</span>: Regional and Applied</em>. <span>Elsevier Inc.</span>
</div>
<div id="ref-melbyComprehensiveSurgicalManagement2008" class="csl-entry" role="doc-biblioentry">
Melby, Spencer J., Suresh Vedantham, Vamsidhar R. Narra, George A. Paletta, Lynnette Khoo-Summers, Matt Driskill, and Robert W. Thompson. 2008. <span>“Comprehensive Surgical Management of the Competitive Athlete with Effort Thrombosis of the Subclavian Vein (<span>Paget-Schroetter</span> Syndrome).”</span> <em>Journal of Vascular Surgery</em> 47 (4): 809–820.e3. <a href="https://doi.org/10.1016/j.jvs.2007.10.057">https://doi.org/10.1016/j.jvs.2007.10.057</a>.
</div>
<div id="ref-modrall2003" class="csl-entry" role="doc-biblioentry">
Modrall, J. Gregory, and Javid Sadjadi. 2003. <span>“Early and Late Presentations of Radiation Arteritis.”</span> <em>Seminars in Vascular Surgery</em> 16 (3): 209–14. <a href="https://doi.org/10.1016/s0895-7967(03)00026-7">https://doi.org/10.1016/s0895-7967(03)00026-7</a>.
</div>
<div id="ref-mohan2016" class="csl-entry" role="doc-biblioentry">
Mohan, Sathish, Andres Schanzer, William P. Robinson, and Francesco A. Aiello. 2016. <span>“Endovascular Management of Radiation-Induced Subclavian and Axillary Artery Aneurysms.”</span> <em>Journal of Vascular Surgery</em> 64 (4): 1135–37. <a href="https://doi.org/10.1016/j.jvs.2015.08.073">https://doi.org/10.1016/j.jvs.2015.08.073</a>.
</div>
<div id="ref-molinaPagetSchroetterSyndromeTreated2007" class="csl-entry" role="doc-biblioentry">
Molina, J. Ernesto, David W. Hunter, and Charles A. Dietz. 2007. <span>“Paget-<span>Schroetter</span> Syndrome Treated with Thrombolytics and Immediate Surgery.”</span> <em>Journal of Vascular Surgery</em> 45 (2): 328–34. <a href="https://doi.org/10.1016/j.jvs.2006.09.052">https://doi.org/10.1016/j.jvs.2006.09.052</a>.
</div>
<div id="ref-mondry2004" class="csl-entry" role="doc-biblioentry">
Mondry, Tammy E., Robert H. Riffenburgh, and Peter A. S. Johnstone. 2004. <span>“Prospective Trial of Complete Decongestive Therapy for Upper Extremity Lymphedema After Breast Cancer Therapy.”</span> <em>Cancer Journal (Sudbury, Mass.)</em> 10 (1): 42-48; discussion 17-19. <a href="https://doi.org/10.1097/00130404-200401000-00009">https://doi.org/10.1097/00130404-200401000-00009</a>.
</div>
<div id="ref-moraschTechniqueSubclavianCarotid2009d" class="csl-entry" role="doc-biblioentry">
Morasch, Mark D. 2009. <span>“Technique for Subclavian to Carotid Transposition, Tips, and Tricks.”</span> <em>Journal of Vascular Surgery</em> 49 (1): 251–54. <a href="https://doi.org/10.1016/j.jvs.2008.10.035">https://doi.org/10.1016/j.jvs.2008.10.035</a>.
</div>
<div id="ref-mordasini2011" class="csl-entry" role="doc-biblioentry">
Mordasini, P., J. Gralla, D.-D. Do, J. Schmidli, B. Keserü, M. Arnold, U. Fischer, G. Schroth, and C. Brekenfeld. 2011. <span>“Percutaneous and Open Retrograde Endovascular Stenting of Symptomatic High-Grade Innominate Artery Stenosis: Technique and Follow-up.”</span> <em>AJNR: American Journal of Neuroradiology</em> 32 (9): 1726–31. <a href="https://doi.org/10.3174/ajnr.A2598">https://doi.org/10.3174/ajnr.A2598</a>.
</div>
<div id="ref-morrell2005" class="csl-entry" role="doc-biblioentry">
Morrell, Rosalyn M., Michele Y. Halyard, Steven E. Schild, Muna S. Ali, Leonard L. Gunderson, and Barbara A. Pockaj. 2005. <span>“Breast Cancer-Related Lymphedema.”</span> <em>Mayo Clinic Proceedings</em> 80 (11): 1480–84. <a href="https://doi.org/10.4065/80.11.1480">https://doi.org/10.4065/80.11.1480</a>.
</div>
<div id="ref-nasser2014" class="csl-entry" role="doc-biblioentry">
Nasser, Felipe, Rafael Noronha Cavalcante, Francisco Leonardo Galastri, Jorge Eduardo de Amorim, Marcus Alexandre Politzer Telles, Fabiellen Berzoini Travassos, Bruna De Fina, and Breno Boueri Affonso. 2014. <span>“Endovascular Stenting of Brachial Artery Occlusion in Critical Hand Ischemia.”</span> <em>Annals of Vascular Surgery</em> 28 (6): 1564.e1–3. <a href="https://doi.org/10.1016/j.avsg.2013.12.022">https://doi.org/10.1016/j.avsg.2013.12.022</a>.
</div>
<div id="ref-olin2018" class="csl-entry" role="doc-biblioentry">
Olin, Jeffrey W. 2018. <span>“Thromboangiitis Obliterans: 110&nbsp;Years Old and Little Progress Made.”</span> <em>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</em> 7 (23): e011214. <a href="https://doi.org/10.1161/JAHA.118.011214">https://doi.org/10.1161/JAHA.118.011214</a>.
</div>
<div id="ref-palchik2008" class="csl-entry" role="doc-biblioentry">
Palchik, Eugene, Andrew M. Bakken, Heather Y. Wolford, David L. Waldman, and Mark G. Davies. 2008. <span>“Evolving Strategies in Treatment of Isolated Symptomatic Innominate Artery Disease.”</span> <em>Vascular and Endovascular Surgery</em> 42 (5): 440–45. <a href="https://doi.org/10.1177/1538574408315994">https://doi.org/10.1177/1538574408315994</a>.
</div>
<div id="ref-reul1991" class="csl-entry" role="doc-biblioentry">
Reul, G. J., M. J. Jacobs, I. D. Gregoric, M. Calderon, J. M. Duncan, D. A. Ott, J. J. Livesay, and D. A. Cooley. 1991. <span>“Innominate Artery Occlusive Disease: Surgical Approach and Long-Term Results.”</span> <em>Journal of Vascular Surgery</em> 14 (3): 405–12. <a href="https://doi.org/10.1067/mva.1991.31287">https://doi.org/10.1067/mva.1991.31287</a>.
</div>
<div id="ref-rinehardtCurrentPracticeThoracic2017" class="csl-entry" role="doc-biblioentry">
Rinehardt, Elena K., John E. Scarborough, and Kyla M. Bennett. 2017. <span>“Current Practice of Thoracic Outlet Decompression Surgery in the <span>United States</span>.”</span> <em>Journal of Vascular Surgery</em> 66 (3): 858–65. <a href="https://doi.org/10.1016/j.jvs.2017.03.436">https://doi.org/10.1016/j.jvs.2017.03.436</a>.
</div>
<div id="ref-rodriguez2016" class="csl-entry" role="doc-biblioentry">
Rodriguez, Joleen Duarte. 2016. <span>“Brachiocephalic Artery Disease Progression Resulting in Complex Steal Phenomena.”</span> <em>Journal of Diagnostic Medical Sonography</em> 32 (3): 173–80. <a href="https://doi.org/10.1177/8756479316649950">https://doi.org/10.1177/8756479316649950</a>.
</div>
<div id="ref-ronel2004" class="csl-entry" role="doc-biblioentry">
Ronel, Daniel N., Estomih Mtui, and William B. Nolan. 2004. <span>“Forearm Compartment Syndrome: Anatomical Analysis of Surgical Approaches to the Deep Space.”</span> <em>Plastic and Reconstructive Surgery</em> 114 (3): 697–705. <a href="https://doi.org/10.1097/01.prs.0000130967.42426.23">https://doi.org/10.1097/01.prs.0000130967.42426.23</a>.
</div>
<div id="ref-sadeghi-azandaryaniThoracicOutletSyndrome2009" class="csl-entry" role="doc-biblioentry">
Sadeghi-Azandaryani, M, D Bürklein, A Ozimek, C Geiger, N Mendl, B Steckmeier, and J Heyn. 2009. <span>“Thoracic Outlet Syndrome: Do We Have Clinical Tests as Predictors for the Outcome After Surgery?”</span> <em>European Journal of Medical Research</em> 14 (10): 443–46. <a href="https://doi.org/10.1186/2047-783X-14-10-443">https://doi.org/10.1186/2047-783X-14-10-443</a>.
</div>
<div id="ref-sahaSubclavianArteryDisease2017" class="csl-entry" role="doc-biblioentry">
Saha, Tisa, Syed Yaseen Naqvi, Omar Abine Ayah, Daniel McCormick, and Sheldon Goldberg. 2017. <span>“Subclavian <span>Artery Disease</span>: <span>Diagnosis</span> and <span>Therapy</span>.”</span> <em>The American Journal of Medicine</em> 130 (4): 409–16. <a href="https://doi.org/10.1016/j.amjmed.2016.12.027">https://doi.org/10.1016/j.amjmed.2016.12.027</a>.
</div>
<div id="ref-sajidUpperLimbDeep2007" class="csl-entry" role="doc-biblioentry">
Sajid, Muhammad S., Naeem Ahmed, Mittal Desai, Daryll Baker, and George Hamilton. 2007. <span>“Upper <span>Limb Deep Vein Thrombosis</span>: <span>A Literature Review</span> to <span>Streamline</span> the <span>Protocol</span> for <span>Management</span>.”</span> <em>Acta Haematologica</em> 118 (1): 10–18. <a href="https://doi.org/10.1159/000101700">https://doi.org/10.1159/000101700</a>.
</div>
<div id="ref-salhanPC214UltrasoundGuidedAnesthetic2016" class="csl-entry" role="doc-biblioentry">
Salhan, Navjeet, Misty Humphries, Samir Sheth, Charles DeMesa, and Julie Freischlag. 2016. <span>“<span>Pc214</span>. <span>Ultrasound-Guided Anesthetic</span> or <span>Botulinum Toxin Injection</span> of the <span>Anterior</span> and <span>Middle Scalene Muscles</span> to <span>Assist With Diagnosis</span> and <span>Treatment</span> of <span>Neurogenic Thoracic Outlet Syndrome</span>.”</span> <em>Journal of Vascular Surgery</em> 63 (6): 218S. <a href="https://doi.org/10.1016/j.jvs.2016.03.365">https://doi.org/10.1016/j.jvs.2016.03.365</a>.
</div>
<div id="ref-sandersDiagnosisThoracicOutlet2007" class="csl-entry" role="doc-biblioentry">
Sanders, Richard J., Sharon L. Hammond, and Neal M. Rao. 2007. <span>“Diagnosis of Thoracic Outlet Syndrome.”</span> <em>Journal of Vascular Surgery</em> 46 (3): 601–4. <a href="https://doi.org/10.1016/j.jvs.2007.04.050">https://doi.org/10.1016/j.jvs.2007.04.050</a>.
</div>
<div id="ref-sekharYearbookVascularEndovascular2018" class="csl-entry" role="doc-biblioentry">
Sekhar, R. 2018. <em>Yearbook of Vascular and Endovascular Surgery-2, 2018</em>. <span>Place of publication not identified</span>: <span>JAYPEE Brothers MEDICAL P</span>.
</div>
<div id="ref-shanmugam137VasculitisOther2019" class="csl-entry" role="doc-biblioentry">
Shanmugam, Victoria K. 2019a. <span>“137. <span>Vasculitis</span> and <span>Other Uncommon Arteriopathies</span>.”</span> In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em>, 16.
</div>
<div id="ref-shanmugam2019" class="csl-entry" role="doc-biblioentry">
———. 2019b. <span>“137. Vasculitis and Other Uncommon Arteriopathies.”</span> In <em>Rutherford’s Vascular Surgery and Endovascular Therapy</em>, 16.
</div>
<div id="ref-sharma2012" class="csl-entry" role="doc-biblioentry">
Sharma, Amit, and Robert A. Schwartz. 2012. <span>“Stewart-Treves Syndrome: Pathogenesis and Management.”</span> <em>Journal of the American Academy of Dermatology</em> 67 (6): 1342–48. <a href="https://doi.org/10.1016/j.jaad.2012.04.028">https://doi.org/10.1016/j.jaad.2012.04.028</a>.
</div>
<div id="ref-shuja117UpperExtremity" class="csl-entry" role="doc-biblioentry">
Shuja, Fahad. n.d. <span>“117. <span>Upper Extremity Arterial Disease</span>: <span>Epidemiology</span>, <span>Etiology</span>, and <span>Diagnostic Evaluation</span>.”</span> In, 11.
</div>
<div id="ref-siracuseInfraclavicularFirstRib2015" class="csl-entry" role="doc-biblioentry">
Siracuse, Jeffrey J., Paul C. Johnston, Douglas W. Jones, Heather L. Gill, Peter H. Connolly, Andrew J. Meltzer, and Darren B. Schneider. 2015. <span>“Infraclavicular First Rib Resection for the Treatment of Acute Venous Thoracic Outlet Syndrome.”</span> <em>Journal of Vascular Surgery: Venous and Lymphatic Disorders</em> 3 (4): 397–400. <a href="https://doi.org/10.1016/j.jvsv.2015.06.002">https://doi.org/10.1016/j.jvsv.2015.06.002</a>.
</div>
<div id="ref-spinelli2010" class="csl-entry" role="doc-biblioentry">
Spinelli, F., F. Benedetto, G. Passari, M. La Spada, G. Carella, F. Stilo, G. De Caridi, and S. Lentini. 2010. <span>“Bypass Surgery for the Treatment of Upper Limb Chronic Ischaemia.”</span> <em>European Journal of Vascular and Endovascular Surgery: The Official Journal of the European Society for Vascular Surgery</em> 39 (2): 165–70. <a href="https://doi.org/10.1016/j.ejvs.2009.10.015">https://doi.org/10.1016/j.ejvs.2009.10.015</a>.
</div>
<div id="ref-jamescstanleyCurrentTherapyVascular2014" class="csl-entry" role="doc-biblioentry">
Stanley, James C, Frank Veith, and Thomas W. Wakefield. 2014. <em>Current <span>Therapy</span> in <span>Vascular</span> and <span>Endovascular Surgery</span></em>. <span>Elsevier Health Sciences</span>.
</div>
<div id="ref-tosti2017" class="csl-entry" role="doc-biblioentry">
Tosti, Rick, Sezai Özkan, Robert M. Schainfeld, and Kyle R. Eberlin. 2017. <span>“Radial Artery Pseudoaneurysm.”</span> <em>The Journal of Hand Surgery</em> 42 (4): 295.e1–6. <a href="https://doi.org/10.1016/j.jhsa.2017.01.024">https://doi.org/10.1016/j.jhsa.2017.01.024</a>.
</div>
<div id="ref-tran2011" class="csl-entry" role="doc-biblioentry">
Tran, Daniel D., and Charles A. Andersen. 2011. <span>“Axillary Sheath Hematomas Causing Neurologic Complications Following Arterial Access.”</span> <em>Annals of Vascular Surgery</em> 25 (5): 697.e5–8. <a href="https://doi.org/10.1016/j.avsg.2010.12.024">https://doi.org/10.1016/j.avsg.2010.12.024</a>.
</div>
<div id="ref-tran2009" class="csl-entry" role="doc-biblioentry">
Tran, Victor, Alexander Shiferson, Anil P. Hingorani, Enrico Ascher, Natalie Marks, Kapil Gopal, Nirav Patel, and Theresa Jacob. 2009. <span>“Use of the StarClose Device for Closure of Inadvertent Subclavian Artery Punctures.”</span> <em>Annals of Vascular Surgery</em> 23 (5): 688.e11–13. <a href="https://doi.org/10.1016/j.avsg.2009.06.005">https://doi.org/10.1016/j.avsg.2009.06.005</a>.
</div>
<div id="ref-treitl2015" class="csl-entry" role="doc-biblioentry">
Treitl, Karla Maria, Cosima König, Maximilian F. Reiser, and Marcus Treitl. 2015. <span>“Complications of Transbrachial Arterial Access for Peripheral Endovascular Interventions.”</span> <em>Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists</em> 22 (1): 63–70. <a href="https://doi.org/10.1177/1526602814564363">https://doi.org/10.1177/1526602814564363</a>.
</div>
<div id="ref-urschelSurgeryRemainsMost2008" class="csl-entry" role="doc-biblioentry">
Urschel, Harold C., and Amit N. Patel. 2008. <span>“Surgery <span>Remains</span> the <span>Most Effective Treatment</span> for <span>Paget-Schroetter Syndrome</span>: 50 <span>Years</span>’ <span>Experience</span>.”</span> <em>The Annals of Thoracic Surgery</em> 86 (1): 254–60. <a href="https://doi.org/10.1016/j.athoracsur.2008.03.021">https://doi.org/10.1016/j.athoracsur.2008.03.021</a>.
</div>
<div id="ref-valentine2005" class="csl-entry" role="doc-biblioentry">
Valentine, R. James, J. Gregory Modrall, and G. Patrick Clagett. 2005. <span>“Hand Ischemia After Radial Artery Cannulation.”</span> <em>Journal of the American College of Surgeons</em> 201 (1): 18–22. <a href="https://doi.org/10.1016/j.jamcollsurg.2005.01.011">https://doi.org/10.1016/j.jamcollsurg.2005.01.011</a>.
</div>
<div id="ref-vemuriClinicalPresentationManagement2017" class="csl-entry" role="doc-biblioentry">
Vemuri, Chandu, Lauren N. McLaughlin, Ahmmad A. Abuirqeba, and Robert W. Thompson. 2017. <span>“Clinical Presentation and Management of Arterial Thoracic Outlet Syndrome.”</span> <em>Journal of Vascular Surgery</em> 65 (5): 1429–39. <a href="https://doi.org/10.1016/j.jvs.2016.11.039">https://doi.org/10.1016/j.jvs.2016.11.039</a>.
</div>
<div id="ref-vemuriDiagnosisTreatmentEffortinduced2016" class="csl-entry" role="doc-biblioentry">
Vemuri, Chandu, Payam Salehi, Jaime Benarroch-Gampel, Lauren N. McLaughlin, and Robert W. Thompson. 2016. <span>“Diagnosis and Treatment of Effort-Induced Thrombosis of the Axillary Subclavian Vein Due to Venous Thoracic Outlet Syndrome.”</span> <em>Journal of Vascular Surgery: Venous and Lymphatic Disorders</em> 4 (4): 485–500. <a href="https://doi.org/10.1016/j.jvsv.2016.01.004">https://doi.org/10.1016/j.jvsv.2016.01.004</a>.
</div>
<div id="ref-vierhout2010" class="csl-entry" role="doc-biblioentry">
Vierhout, B. P., C. J. Zeebregts, J. J. A. M. van den Dungen, and M. M. P. J. Reijnen. 2010. <span>“Changing Profiles of Diagnostic and Treatment Options in Subclavian Artery Aneurysms.”</span> <em>European Journal of Vascular and Endovascular Surgery</em> 40 (1): 27–34. <a href="https://doi.org/10.1016/j.ejvs.2010.03.011">https://doi.org/10.1016/j.ejvs.2010.03.011</a>.
</div>
<div id="ref-vandervliet1995" class="csl-entry" role="doc-biblioentry">
Vliet, J. A. van der, H. W. Palamba, D. M. Scharn, S. F. S. van Roye, and F. G. M. Buskens. 1995. <span>“Arterial Reconstruction for Subclavian Obstructive Disease: A Comparison of Extrathoracic Procedures.”</span> <em>European Journal of Vascular and Endovascular Surgery</em> 9 (4): 454–58. <a href="https://doi.org/10.1016/S1078-5884(05)80015-2">https://doi.org/10.1016/S1078-5884(05)80015-2</a>.
</div>
<div id="ref-voigtOutcomesCarotidsubclavianBypass2019" class="csl-entry" role="doc-biblioentry">
Voigt, Soraya L., Muath Bishawi, David Ranney, Babatunde Yerokun, Richard L. McCann, and G. Chad Hughes. 2019. <span>“Outcomes of Carotid-Subclavian Bypass Performed in the Setting of Thoracic Endovascular Aortic Repair.”</span> <em>Journal of Vascular Surgery</em> 69 (3): 701–9. <a href="https://doi.org/10.1016/j.jvs.2018.07.022">https://doi.org/10.1016/j.jvs.2018.07.022</a>.
</div>
<div id="ref-wahlberg2006" class="csl-entry" role="doc-biblioentry">
Wahlberg, Eric, Jerry Goldstone, and Pär Olofsson. 2006. <em>Emergency Vascular Surgery: A Practical Guide</em>. Medicine (Springer-11650; ZDB-2-SME). Springer-Verlag. Springer e-books.
</div>
<div id="ref-warren2007" class="csl-entry" role="doc-biblioentry">
Warren, Anne G., Håkan Brorson, Loren J. Borud, and Sumner A. Slavin. 2007. <span>“Lymphedema: A Comprehensive Review.”</span> <em>Annals of Plastic Surgery</em> 59 (4): 464–72. <a href="https://doi.org/10.1097/01.sap.0000257149.42922.7e">https://doi.org/10.1097/01.sap.0000257149.42922.7e</a>.
</div>
<div id="ref-weyand2003" class="csl-entry" role="doc-biblioentry">
Weyand, Cornelia M., and Jörg J. Goronzy. 2003. <span>“Medium- and Large-Vessel Vasculitis.”</span> <em>The New England Journal of Medicine</em> 349 (2): 160–69. <a href="https://doi.org/10.1056/NEJMra022694">https://doi.org/10.1056/NEJMra022694</a>.
</div>
<div id="ref-wigley2016" class="csl-entry" role="doc-biblioentry">
Wigley, Fredrick M., and Nicholas A. Flavahan. 2016. <span>“Raynaud’s Phenomenon.”</span> <em>The New England Journal of Medicine</em> 375 (6): 556–65. <a href="https://doi.org/10.1056/NEJMra1507638">https://doi.org/10.1056/NEJMra1507638</a>.
</div>
<div id="ref-wilsonFibrinolyticTherapyIdiopathic1990" class="csl-entry" role="doc-biblioentry">
Wilson, Jonathan J., Catherine A. Zahn, and Harold Newman. 1990. <span>“Fibrinolytic Therapy for Idiopathic Subclavian-Axillary Vein Thrombosis.”</span> <em>The American Journal of Surgery</em> 159 (2): 208–10. <a href="https://doi.org/10.1016/S0002-9610(05)80262-4">https://doi.org/10.1016/S0002-9610(05)80262-4</a>.
</div>
<div id="ref-yoon2015" class="csl-entry" role="doc-biblioentry">
Yoon, Dustin Y., Suman Annambhotla, Scott A. Resnick, Mark K. Eskandari, and Heron E. Rodriguez. 2015. <span>“Inadvertent Arterial Placement of Central Venous Catheters: Diagnostic and Therapeutic Strategies.”</span> <em>Annals of Vascular Surgery</em> 29 (8): 1567–74. <a href="https://doi.org/10.1016/j.avsg.2015.05.030">https://doi.org/10.1016/j.avsg.2015.05.030</a>.
</div>
<div id="ref-ziomek1986" class="csl-entry" role="doc-biblioentry">
Ziomek, S., W. J. Quiñones-Baldrich, R. W. Busuttil, J. D. Baker, H. I. Machleder, and W. S. Moore. 1986. <span>“The Superiority of Synthetic Arterial Grafts over Autologous Veins in Carotid-Subclavian Bypass.”</span> <em>Journal of Vascular Surgery</em> 3 (1): 140–45.
</div>
</div>
</section>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    setTimeout(function() {
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      let href = ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const cites = ref.parentNode.getAttribute('data-cites').split(' ');
    tippyHover(ref, function() {
      var popup = window.document.createElement('div');
      cites.forEach(function(cite) {
        var citeDiv = window.document.createElement('div');
        citeDiv.classList.add('hanging-indent');
        citeDiv.classList.add('csl-entry');
        var biblioDiv = window.document.getElementById('ref-' + cite);
        if (biblioDiv) {
          citeDiv.innerHTML = biblioDiv.innerHTML;
        }
        popup.appendChild(citeDiv);
      });
      return popup.innerHTML;
    });
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="./cerebrovascular.html" class="pagination-link">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Cerebrovascular</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./hemodialysis.html" class="pagination-link">
        <span class="nav-page-text"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Angioaccess</span></span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->



</body></html>